Document and Entity Information
Document and Entity Information - shares | 3 Months Ended | |
Nov. 30, 2017 | Jan. 15, 2018 | |
Document and Entity Information: | ||
Entity Registrant Name | Kush Bottles, Inc. | |
Entity Central Index Key | 1,604,627 | |
Trading Symbol | kshb | |
Current Fiscal Year End Date | --08-31 | |
Entity Filer Category | Smaller Reporting Company | |
Entity Common Stock, Shares Outstanding | 61,786,868 | |
Document Type | 10-Q | |
Document Period End Date | Nov. 30, 2017 | |
Amendment Flag | false | |
Document Fiscal Year Focus | 2,018 | |
Document Fiscal Period Focus | Q1 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) | Nov. 30, 2017 | Aug. 31, 2017 |
CURRENT ASSETS | ||
Cash | $ 5,549,431 | $ 916,984 |
Accounts receivable, net of allowance | 2,764,713 | 1,695,303 |
Prepaid expenses and other current assets | 3,146,759 | 1,625,689 |
Inventory | 3,850,678 | 3,754,171 |
Total Current Assets | 15,311,581 | 7,992,147 |
Goodwill | 34,247,344 | 34,247,344 |
Intangible assets, net | 3,586,489 | 3,730,287 |
Deposits | 50,235 | 50,235 |
Deferred tax asset | 30,081 | 30,081 |
Property and equipment, net | 924,872 | 931,763 |
TOTAL ASSETS | 54,150,602 | 46,981,857 |
CURRENT LIABILITIES | ||
Accounts payable | 1,889,378 | 1,039,889 |
Accrued expenses and other current liabilities | 1,264,054 | 993,186 |
Contingent cash consideration | 1,735,000 | 1,820,000 |
Notes payable - current portion | 358,253 | 689,450 |
Line of credit - current portion | 1,500,000 | |
Total Current Liabilities | 6,746,685 | 4,542,525 |
LONG-TERM DEBT | ||
Deferred tax liability | 1,424,173 | 1,424,173 |
Notes payable | 26,820 | 34,513 |
TOTAL LIABILITIES | 8,197,678 | 6,001,211 |
COMMITMENTS and CONTINGENCIES | ||
STOCKHOLDERS' EQUITY | ||
Preferred stock, $0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding | ||
Common stock, $0.001 par value, 265,000,000 shares authorized, 60,006,178 and 58,607,066 shares issued and outstanding, respectively | 60,006 | 58,607 |
Additional paid-in capital | 43,841,497 | 41,529,283 |
Stock Payables | 2,564,050 | |
Accumulated deficit | (512,629) | (607,244) |
Total Stockholders' Equity | 45,952,924 | 40,980,646 |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ 54,150,602 | $ 46,981,857 |
Condensed Consolidated Balance3
Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares | Nov. 30, 2017 | Aug. 31, 2017 |
Statement of Financial Position [Abstract] | ||
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized | 10,000,000 | 10,000,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 265,000,000 | 265,000,000 |
Common stock, shares issued | 60,006,178 | 58,607,066 |
Common stock, shares outstanding | 60,006,178 | 58,607,066 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | |
Nov. 30, 2017 | Nov. 30, 2016 | |
Income Statement [Abstract] | ||
REVENUE | $ 8,847,115 | $ 2,472,295 |
COST OF GOODS SOLD | 6,162,120 | 1,637,652 |
GROSS PROFIT | 2,684,995 | 834,643 |
OPERATING EXPENSES | ||
Depreciation and amortization | 201,814 | 9,304 |
Stock compensation expense | 381,743 | 115,244 |
Selling, general and administrative | 1,949,995 | 847,076 |
Total Operating Expenses | 2,533,552 | 971,624 |
INCOME (LOSS) FROM OPERATIONS | 151,443 | (136,981) |
OTHER INCOME (EXPENSES) | ||
Other expense | (23,944) | |
Interest expense | (2,413) | (1,033) |
Total Other Income (Expenses) | (2,413) | (24,977) |
INCOME (LOSS) BEFORE INCOME TAXES | 149,030 | (161,958) |
PROVISION FOR INCOME TAXES | 54,415 | |
NET INCOME (LOSS) | $ 94,615 | $ (161,958) |
BASIC INCOME (LOSS) PER SHARE (in dollars per share) | $ 0 | $ 0 |
DILUTED INCOME (LOSS) PER SHARE (in dollars per share) | $ 0 | $ 0 |
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC (in shares) | 59,194,323 | 48,713,496 |
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED (in shares) | 65,908,368 | 50,511,299 |
Condensed Consolidated Stateme5
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) | 3 Months Ended | |
Nov. 30, 2017 | Nov. 30, 2016 | |
CASH FLOWS FROM OPERATING ACTIVITIES | ||
Net income (loss) | $ 94,615 | $ (161,958) |
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | ||
Depreciation and amortization | 201,814 | 29,735 |
Depreciation cost of goods sold | 41,776 | |
Stock compensation expense | 381,743 | 115,244 |
Changes in operating assets and liabilities | ||
Accounts receivable | (1,069,410) | (66,174) |
Prepaids | (1,545,793) | (366,550) |
Inventory | (96,507) | (94,262) |
Accounts payable | 760,577 | 176,696 |
Accrued expenses and other current liabilities | 270,868 | (111,351) |
Net cash used in operating activities | (960,317) | (478,620) |
CASH FLOWS FROM INVESTING ACTIVITIES | ||
Acquisition of web domain | (44,321) | |
Purchase of property and equipment | (48,580) | (164,976) |
Net cash used in investing activities | (92,901) | (164,976) |
CASH FLOWS FROM FINANCING ACTIVITIES | ||
Repayment of car loan | (5,495) | |
Earn out payable | (85,000) | |
Repayment of note payable | (333,395) | (4,967) |
Proceeds from line of credit | 1,500,000 | |
Proceeds from sale of stock | 4,609,555 | 1,621,999 |
Net cash provided by financing activities | 5,685,665 | 1,617,032 |
NET INCREASE (DECREASE) IN CASH | 4,632,447 | 973,436 |
CASH AT BEGINNING OF PERIOD | 916,984 | 1,027,003 |
CASH AT END OF PERIOD | 5,549,431 | 2,000,439 |
CASH PAID FOR: | ||
Interest | 2,370 | 1,033 |
Income taxes | 0 | 0 |
NON-CASH INVESTING AND FINANCING ACTIVITIES | ||
Services prepaid for in common stock | $ 34,077 | $ 103,617 |
NATURE OF BUSINESS AND SIGNIFIC
NATURE OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES | 3 Months Ended |
Nov. 30, 2017 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
NATURE OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES | NOTE 1 – NATURE OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES Nature of Business Kush Bottles, Inc. (“the Company”) was incorporated in the state of Nevada on February 26, 2014. The Company specializes in the wholesale distribution of packaging supplies for the cannabis industry. The Company’s wholly owned subsidiary Kim International Corporation (KIM), a California corporation, was originally incorporated as Hy Gro Economics Corporation ("Hy Gro") on December 2, 2010. On October 30, 2012, Hy Gro amended its articles of incorporation to reflect a name change to KIM International Corporation (KIM). On March 4, 2014, the shareholders of KIM exchanged all 10,000 of their common shares for 32,400,000 common shares of Kush Bottles, Inc. The operations of KIM became the operations of Kush after the share exchange and accordingly the transaction is accounted for as a recapitalization of KIM whereby the historical financial statements of KIM are presented as the historical financial statements of the combined entity. KIM was the acquiring entity in accordance with ASC 805, Business Combinations. The accumulated losses of KIM were carried forward after the completion of the share exchange. Operations prior to the share exchange were those of KIM. Acquisition of CMP Wellness, LLC On May 1, 2017, the Company entered into an agreement of merger agreement with Lancer West Enterprises, Inc. a California corporation, Walnut Ventures, a California corporation, Jason Manasse, an individual, and Theodore Nicols, an individual, pursuant to which each of Lancer West Enterprises, Inc. and Walnut Ventures were merged with and into Merger Sub, with Merger Sub as the surviving corporation, resulting in the Company’s indirect acquisition of CMP Wellness, LLC, a California limited liability company, which prior to the merger, was owned 100% by Lancer West Enterprises, Inc. and Walnut Ventures. CMP Wellness, LLC is a distributor of vaporizers, cartridges and accessories. The acquisition was accounted for using the acquisition method of accounting in accordance with ASC 805, Business Combinations. The purchase price payable to Jason Manasse and Theodore Nicols at the closing of the merger in exchange for consummating the merger was comprised of an aggregate of $1,500,000 in cash, unsecured promissory notes in the aggregate principal amount of approximately $770,820, having a one-year maturity, and an aggregate of 7,800,000 restricted shares of the Company’s common stock. The purchase price is subject to customary post-closing adjustments with respect to confirmation of the levels of working capital and cash held by CMP Wellness, LLC as of the closing. During the one-year period following the closing, Jason Manasse and Theodore Nicols may become entitled to receive up to an additional approximately $1,905,000 in cash, in the aggregate, and approximately 4,740,960 shares of common stock of the Company, in the aggregate, based on the future performance of CMP Wellness, LLC (See Note 2). Basis of Presentation The accompanying unaudited condensed consolidated financial statements and related notes include the activity of the Company and its wholly owned subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information. All intercompany balances and transactions have been eliminated. Accordingly, they do not include all of the information and notes required by generally accepted accounting principles for annual financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. Our operating results for the three month period ended November 30, 2017 are not necessarily indicative of the results that may be expected for the fiscal year ended August 31, 2018, or for any other period. These unaudited condensed consolidated financial statements and notes should be read in conjunction with the Company’s audited consolidated financial statements and accompanying notes for the fiscal year ended August 31, 2017. The condensed consolidated balance sheet as of August 31, 2017 included herein was derived from the audited financial statements as of that date, but does not include all disclosures including notes required by GAAP. There have been no changes to our significant accounting policies described in our Annual Report on Form 10-K for the fiscal year ended August 31, 2017 that have had a material impact on our condensed consolidated financial statements and related notes. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amount of revenues and expenses during the reporting period. Significant estimates relied upon in preparing these unaudited condensed consolidated financial statements include revenue recognition, accounts receivable reserves, inventory and related reserves, valuations and purchase price allocations related to business combinations, expected future cash flows used to evaluate the recoverability of long-lived assets, estimated fair values of long-lived assets used to record impairment charges related to intangible assets and goodwill, amortization periods, accrued expenses, stock-based compensation, and recoverability of the Company’s net deferred tax assets and any related valuation allowance. Although the Company regularly assesses these estimates, actual results could differ materially from these estimates. Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances. Actual results may differ from management’s estimates if past experience or other assumptions do not turn out to be substantially accurate. The Company is subject to a number of risks similar to those of other companies of similar size and having a focus of serving the cannabis industry, including, the development stage of certain products, competition, limited number of suppliers, integration of acquisitions, substantial indebtedness, government regulations, protection of proprietary rights, and dependence on key individuals. Segments The Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial information is evaluated regularly by the chief operating decision maker, who is the chief executive officer, in deciding how to allocate resources and assessing performance. Over the past few years, the Company has completed a number of acquisitions. These acquisitions have allowed the Company to expand its offerings, presence and reach in the cannabis industry. While the Company has offerings in multiple geographic locations for its products for the cannabis industry, including as a result of the Company's acquisitions, the Company’s business operates in one operating segment because the majority of the Company's offerings operate similarly, and the Company’s chief operating decision maker evaluates the Company’s financial information and resources and assesses the performance of these resources on a consolidated basis. Since the Company operates in one operating segment, all required financial segment information can be found in the unaudited condensed consolidated financial statements. Cash and Cash Equivalents The Company considers cash and cash equivalents to consist of cash on hand and investments having an original maturity of 90 days or less that are readily convertible into cash. The Company invests its cash and cash equivalents with financial institutions with highly rated credit and monitors the amount on deposit at the financial institution. As of November 30, 2017 and August 31, 2017, the Company had $5,549,431 and $916,984 respectively. Accounts Receivable Trade accounts receivable are carried at their estimated collectible amounts. Trade credit is generally extended on a short-term basis, thus trade receivables do not bear interest. Trade accounts receivables are periodically evaluated for collectability based on past credit history and their current financial condition. The Company’s allowance for doubtful accounts was $40,478 and $25,000 as of November 30, 2017 and August 31, 2017, respectively. Inventory Inventories are stated at the lower of cost or net realizable value using the first-in first out (FIFO) method. The Company’s inventory consists of finished goods of $3,850,678 and $3,754,171 as of November 30, 2017 and August 31, 2017, respectively. Property and Equipment Property and equipment is recorded at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the shorter of estimated useful life of the asset or the lease term, after the asset is placed in service. The estimated useful lives of the property and equipment are generally as follows: computer software acquired for internal use, three to seven years; computer equipment, two to three years; leasehold improvements, three to life of lease; and furniture and equipment, one to 7 years. Gains and losses from the retirement or disposition of property and equipment are included in operations in the period incurred. Maintenance and repairs are expensed as incurred. Fair Value of Financial Instruments The fair value of certain of our financial instruments, including cash and cash equivalents, receivables, other current assets, accounts payable, accrued compensation and employee benefits, other accrued liabilities and notes payable, approximate their carrying amounts because of the short-term maturity of these instruments. Concentration of Risk The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, and accounts receivable. Collateral is not required for accounts receivable. The Company maintains an allowance for its doubtful accounts receivable. This allowance is based upon historical loss patterns, the number of days that billings are past due and an evaluation of the potential risk of loss associated with delinquent accounts. Receivables are written-off and charged against its recorded allowance when the Company has exhausted collection efforts without success. The Company’s losses related to collection of trade receivables have consistently been within management’s expectations. Due to these factors, no additional credit risk beyond amounts provided for collection losses, which the Company reevaluates on a monthly basis based on specific review of receivable aging and the period that any receivables are beyond the standard payment terms, is believed by management to be probable in the Company’s accounts receivable. Although, the Company is directly affected by the overall financial condition of the cannabis industry, management does not believe significant credit risk exists as of November 30, 2017. The Company generally has not experienced any material losses related to receivables from individual customers or groups of customers. The Company maintains an allowance for doubtful accounts based on accounts past due according to contractual terms and historical collection experience. Actual losses when incurred are charged to the allowance. The Company purchases products from a small number of suppliers. A change in or loss of these suppliers could cause a delay in filling customer orders and a possible loss of sales, which would adversely affect results of operations; however, management believes that suitable replacement suppliers could be obtained in such an event. Intangible Assets acquired through Business Combinations Intangible assets, domain name, trademarks and non-compete agreements that are deemed to have a definite life are amortized over their estimated useful lives and intangible assets with an indefinite life are assessed for impairment at least annually. Each period, the Company evaluates the estimated remaining useful life of its intangible assets and whether events or changes in circumstances warrant a revision to the remaining period of amortization. Impairment Assessment The Company evaluates intangible assets and long-lived assets for possible impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. This includes but is not limited to significant adverse changes in business climate, market conditions, or other events that indicate an asset's carrying amount may not be recoverable. Recoverability of these assets is measured by comparison of the carrying amount of each asset to the future undiscounted cash flows the asset is expected to generate. If the undiscounted cash flows used in the test for recoverability are less than the carrying amount of these assets, the carrying amount of such assets is reduced to fair value. The Company evaluates and tests the recoverability of its goodwill for impairment at least annually during its fourth quarter of each fiscal year or more often if and when circumstances indicate that goodwill may not be recoverable. There was no impairment of intangible assets, long-lived assets or goodwill during the three months ended November 30, 2017 and for the fiscal year ended August 31, 2017. Valuation of Business Combinations and Acquisition of Intangible Assets The Company records intangible assets acquired in business combinations and acquisitions of intangible assets under the purchase method of accounting. The Company accounts for acquisitions in accordance with FASB ASC Topic 805, Business Combinations The Company uses the income approach, the relief from royalty method (both a market and income method), and the with and without method to determine the fair values of its purchased intangible assets. The Company uses the probability-weighted expected return method (an income approach) to determine the appropriate amount of contingent consideration to include in the purchase price for an acquisition. The Company bases its revenue assumptions on estimates of relevant market sizes, expected market growth rates, expected industry trends and expected product introductions by competitors. In arriving at the value. The Company bases the discount rate used to arrive at a present value as of the date of acquisition on the time value of money and cannabis industry investment risk factors. For the intangible assets acquired, the Company used risk-adjusted discount rates ranging from 19% to 26% to discount its projected cash flows. The Company believes that the estimated purchased intangible asset amounts so determined represent the fair value at the date of acquisition and do not exceed the amount a third party would pay for the projects. The Company also used the income approach (probably weighted cash flow), as described above, to determine the estimated fair value of certain identifiable intangibles assets including domain names and tradenames. Domain names represent established relationships with customers, which provides a ready channel for the sale of additional products and services. Tradenames represent acquired product names that the Company intends to continue to utilize. The Company used the with and without method to ascertain the fair value of the non-competition agreement. Goodwill and Intangible Assets Goodwill and intangible assets that have indefinite useful lives are not amortized but are evaluated for impairment annually or whenever events or changes in circumstances indicate that the carrying value may not be recoverable. The Company records intangible assets at historical cost. The Company amortizes its intangible assets that have finite lives using either the straight-line method or based on estimated future cash flows to approximate the pattern in which the economic benefit of the asset will be utilized. Amortization is recorded over the estimated useful lives ranging from four to six years. The Company reviews intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life. Conditions that would indicate impairment and trigger a more frequent impairment assessment include, but are not limited to, a significant adverse change in legal factors or business climate that could affect the value of an asset, or an adverse action or assessment by a regulator. If the carrying value of an asset exceeds its undiscounted cash flows, the Company will write-down the carrying value of the intangible asset to its fair value in the period identified. The Company generally calculates fair value as the present value of estimated future cash flows to be generated by the asset using a risk-adjusted discount rate. If the estimate of an intangible asset’s remaining useful life is changed, the Company will amortize the remaining carrying value of the intangible asset prospectively over the revised remaining useful life. Consistent with prior years, the Company conducted its annual impairment test of goodwill during the fourth quarter of fiscal 2017. The estimate of fair value requires significant judgment. Any loss resulting from an impairment test would be reflected in operating income in the Company’s unaudited condensed consolidated statements of income. The annual impairment testing process is subjective and requires judgment at many points throughout the analysis. If these estimates or their related assumptions change in the future, the Company may be required to record impairment charges for these assets not previously recorded. Business Combinations The Company uses its best estimates and assumptions to accurately assign fair value to the tangible and intangible assets acquired and liabilities assumed at the acquisition date. The Company’s estimates are inherently uncertain and subject to refinement. During the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments to the fair value of these tangible and intangible assets acquired and liabilities assumed, with the corresponding offset to goodwill. In addition, uncertain tax positions and tax-related valuation allowances are initially established in connection with a business combination as of the acquisition date. The Company continues to collect information and reevaluates these estimates and assumptions quarterly and records any adjustments to the Company’s preliminary estimates to goodwill provided that the Company is within the measurement period. Upon the conclusion of the measurement period or final determination of the fair value of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the Company’s condensed consolidated statements of operations. Earnings (Loss) Per Share The Company computes earnings per share under Accounting Standards Codification subtopic 260-10, "Earnings per Share" (“ASC 260-10”). Basic net income (loss) per common share is computed by dividing net loss by the weighted average number of shares of common stock. Diluted net loss per share is computed using the weighted average number of common and common stock equivalent shares outstanding during the period. Basic earnings per share are computed by dividing net earnings by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share are computed by dividing net earnings by the sum of (a) the weighted average number of shares of common stock outstanding during the period and (b) the potentially dilutive securities outstanding during the period. Stock options are potentially dilutive securities; and the number of dilutive options is computed using the treasury stock method. The effect of the contingent equity consideration relating to the acquisition of CMP is also factored into the calculation of dilutive securities. The following table sets forth the calculation of basic and diluted earnings per share: Three months ended November 30, November 30, 2017 2016 Net income (loss) $ 94,615 $ (161,958 ) Weighted average common shares outstanding for basic EPS 59,194,323 48,713,496 Net effect of dilutive options 1,973,085 1,797,803 Net effect of contingent equity consideration 4,740,960 — Weighted average common shares outstanding for diluted EPS 65,908,368 50,511,299 Basic earnings (loss) per share $ 0.00 $ (0.00 ) Diluted earnings (loss) per share $ 0.00 $ (0.00 ) Comprehensive Income (loss) Comprehensive income (loss) is the change in the Company’s equity (net assets) during each period from transactions and other events and circumstances from non-owner sources. During the quarters ended November 30, 2017 and 2016, the Company had no elements of comprehensive income or loss. Revenue Recognition It is the Company’s policy that revenues from product sales is recognized in accordance with ASC 605 "Revenue Recognition". Four basic criteria must be met before revenue can be recognized; (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management’s judgments regarding fixed nature in selling prices of the products delivered and the collectability of those amounts. The Company has not implemented any specific rebate programs. Provisions for discounts to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. The Company has not established a formal customer incentive program, but considers and accommodates discounts to certain customers on a case by case basis, including by way of example, for volume shipping or for certain new customers with orders over a specific discretionary dollar threshold. The Company classifies the reimbursement by customers of shipping and handling costs as revenue and the associated cost as cost of revenue. As of November 30, 2017 and, 2016, the Company had a refund allowance of $0 and $0, respectively. Consistent with ASC 605-15-25-1, the Company considers factors such as historical return of products, estimated remaining shelf life, price changes from competitors, and introductions of competing products in establishing a refund allowance. The Company recognizes revenues as risk and title to products transfers to the customer (which generally occurs at the time shipment is made), the sales price is fixed or determinable, and collectability is reasonably assured. The Company defers any revenue for which the product was not delivered or is subject to refund until such time that the Company and the customer jointly determine that the product has been delivered or no refund will be required. Warranty Costs The Company has not had any historical warranty related expenditures from the sales of its products, which if incurred would result in the return of any defective products by customers Share-based Compensation The Company account for its stock based award in accordance with Accounting Standards Codification subtopic 718-10, "Compensation", which requires fair value measurement and recognition of compensation expense for all share-based payment awards made to employees and directors, including restricted stock awards. The Company estimates the fair value of stock using the stock price on the date of the approval of the award. The fair value is then expensed over the requisite service periods of the awards, which is generally the performance period and the related amount is recognized in the consolidated statements of operations. Advertising The Company conducts advertising for the promotion of its products and services. In accordance with ASC Topic 720-35-25, advertising costs are charged to operations when incurred. Income Taxes The Company accounts for income taxes in accordance with accounting guidance now codified as FASB ASC 740, "Income Taxes," which requires that the Company recognize deferred tax liabilities and assets based on the differences between the financial statement carrying amounts and the tax bases of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse. Deferred income tax benefit (expense) results from the change in net deferred tax assets or deferred tax liabilities. A valuation allowance is recorded when it is more likely than not that some or all deferred tax assets will not be realized. The Company applies the provisions of ASC 740, "Accounting for Uncertainty in Income Taxes". The ASC prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The ASC provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. The Company utilizes a two-step approach to recognizing and measuring uncertain tax positions (tax contingencies). The first step evaluates the tax position for recognition by determining if the weight of available evidence indicates it is more likely than not that we will sustain the position on audit, including resolution of related appeals or litigation processes. The second step measures the tax benefit as the largest amount more than 50% likely of being realized upon ultimate settlement. The Company did not identify any material uncertain tax positions on returns that have been filed or that will be filed. The Company did not recognize any interest or penalties for unrecognized tax benefits during the three month ended November 30, 2017 and the fiscal year ended August 31, 2017, nor were any interest or penalties accrued as of November 30, 2017 and August 31, 2016. Fair Value of Financial Instruments The Company adopted ASC 820 which defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). The standard outlines a valuation framework and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements and the related disclosures. Under this standard certain assets and liabilities must be measured at fair value, and disclosures are required for items measured at fair value The Company currently does not have non-financial assets or non-financial liabilities that are required to be measured at fair value on a recurring basis. The Company’s financial assets and liabilities are measured using inputs from the three levels of the fair value hierarchy. The three levels are as follows Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. The fair value of the Company’s cash is based on quoted prices and therefore classified as Level 1 Level 2 - Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates, yield curves, etc.), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs) Level 3 - Unobservable inputs that reflect management’s assumptions about the assumptions that market participants would use in pricing the asset or liability Application of Valuation Hierarchy Financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The following is a description of the valuation methodology used to measure fair value, as well as the general classification of such instruments pursuant to the valuation hierarchy The Company has a contingent consideration liability of $1,820,000, which consists of contingent cash consideration of $1,820,000 resulting from the acquisition of CMP (Note 2). The contingent consideration liability is calculated based on the weighted average probability of meeting certain milestones. This liability is remeasured at each reporting period. The Company had no other financial assets or liabilities that are measured at fair value on a recurring basis as of November 30, 2017 The following table summarizes, for assets or liabilities measured at fair value, the respective fair value and the classification by level of input within the fair value hierarchy: Fair Value Measurement at Reporting Date Using Description November 30, 2017 Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Contingent consideration liability $ 1,820,000 $ — $ — $ 1,820,000 The Company classifies its contingent consideration liability within Level 3 as the valuation inputs are based on quoted market prices and market observable data. During the three months ended November 30, 2017, the Company did not recognize any change in the fair value of its contingent consideration liability of $1,820,000. Recently Issued Accounting Pronouncements In September 2017, the FASB issued Accounting Standards Update (ASU) No. 2017-13, “Revenue Recognition (Topic 605), Revenue from Contracts with Customers (Topic 606), Leases (Topic 840), and Leases (Topic 842): Amendments to SEC Paragraphs Pursuant to the Staff Announcement at the July 20, 2017 EITF Meeting and Rescission of Prior SEC Staff Announcements and Observer Comments.” In January 2017, the FASB issued Accounting Standards Update No. 2017-04, Simplifying the Test for Goodwill Impairment In January 2017, the FASB issued Accounting Standards Update No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business In August, 2016, the FASB issued Accounting Standards Update No. 2016-15, Classification of Certain Cash Receipts and Cash Payments (a consensus of the Emerging Issues Task Force) Statement of Cash Flows In May 2016, accounting guidance was issued to clarify the not yet effective revenue recognition guidance issued in May 2014. This additional guidance does not change the core principle of the revenue recognition guidance issued in May 2014, rather, it provides clarification of accounting for collections of sales taxes as well as recognition of revenue (i) associated with contract modifications, (ii) for noncash consideration, and (iii) based on the collectability of the consideration from the customer. The guidance also specifies when a contract should be considered “completed” for purposes of applying the transition guidance. The effective date and transition requirements for this guidance are the same as the effective date and transition requirements for the guidance previously issued in 2014, which is effective for interim and annual periods beginning on or after December 15, 2017. The new standard also permits two methods of adoption: retrospectively to each prior reporting period presented (full retrospective method), or retrospectively with the cumulative effect of initially applying the guidance recognized at the date of initial application (the modified retrospective method). The Company’s management currently anticipates adopting the standard using the modified retrospective method. While management is still in the process of completing the analysis on the impact this guidance will have on the Company’s consolidated financial statements, related disclosures, and its internal controls over financial reporting. The Company has not yet determined whether the impact that this new guidance will be material to its consolidated financial statements. In March 2016, the FASB issued ASU 2016-09, Compensation—Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) In January 2016, the FASB issued ASU 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities Other Accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expect |
ACQUISITION OF CMP WELLNESS, LL
ACQUISITION OF CMP WELLNESS, LLC | 3 Months Ended |
Nov. 30, 2017 | |
Business Combinations [Abstract] | |
ACQUISITION OF CMP WELLNESS, LLC | NOTE 2 – ACQUISITION OF CMP WELLNESS, LLC On May 1, 2017 (“Merger Date”), the Company and KBCMP, Inc., a Delaware corporation and newly formed wholly-owned subsidiary of the Company (“Merger Sub”), entered into an Agreement of Merger (the “Merger Agreement”) with Lancer West Enterprises, Inc. a California corporation and Walnut Ventures, a California corporation, pursuant to which each of Lancer West Enterprises, Inc. and Walnut Ventures were merged with and into Merger Sub, with Merger Sub as the surviving corporation, resulting in the Company’s indirect acquisition of CMP Wellness, LLC (“CMP”), a California limited liability company, which prior to the merger, was owned 100% by Lancer West Enterprises, Inc. and Walnut Ventures. Membership interest in CMP was the sole and only asset of Lancer West Enterprises, Inc. and Walnut Ventures. As a result, CMP became a wholly-owned subsidiary of the Company. CMP is a distributor of vaporizers, cartridges and accessories. The acquisition consideration consisted of a cash payment of $1,500,000, unsecured promissory notes in the aggregate principal amount of approximately $770,820, having a one-year maturity, and an aggregate of 7,800,000 restricted shares of the Company’s common stock (equal to13.0% of the Company’s common stock outstanding as of November 30, 2017). During the one-year period following the closing, the two sellers of CMP may become entitled to receive up to an additional $1,905,000 in cash, in the aggregate, and 4,740,960 shares of common stock of the Company, in the aggregate, based on the gross profit generated by CMP product line for the period from May 1, 2017 to April 30, 2018. Per the terms of the Merger Agreement, post-closing adjustments to CMP’s working capital is directly offset to the unsecured promissory notes payable. Management has estimated that the post-closing working capital adjustments amounted to $104,032, which management estimates will result in a decrease of the unsecured promissory notes payable from $770,820 to $666,788. In accordance with ASC 805, management has evaluated the estimated fair value of the contingent consideration based a probability-weighted assessment of the occurrence of CMP reaching certain gross profit earnout targets. The Company initially recorded a contingent liability for the contingent cash consideration of $1,735,375 $1,905,000 and recorded contingent equity consideration of $10,763,760. Based on information obtained during the fourth fiscal quarter, the Company revised its estimate of the contingent cash consideration from $1,735,375 to $1,905,000, and its estimate of the contingent equity consideration from $10,763,760 to $11,852,400. The fair value of the contingent equity consideration is recorded in additional paid in capital. CMP’s assets acquired and liabilities assumed are recorded at their acquisition-date fair values. As part of the purchase price allocation, all intangible assets that were a part of the acquisition were identified and valued. It was determined that only non-competition agreements and trade name had separately identifiable values. Trade name represents the CMP product names that the Company intends to continue to use. The deferred income tax liability relates to the tax effect of acquired identifiable intangible assets as such amounts are not deductible for tax purposes. For the acquisition discussed above, goodwill represents the excess of the purchase price over the net identifiable tangible and intangible assets acquired. The Company determined that the acquisition of CMP resulted in the recognition of goodwill primarily because of synergies unique to the Company and the strength of its acquired workforce. The results of operations of CMP were consolidated beginning on the date of the merger. Acquisition-related transaction costs are not included as a component of consideration transferred, but are accounted for as an expense in the period in which the costs are incurred. Any excess of the acquisition consideration over the fair value of tangible and intangible assets acquired and liabilities assumed is allocated to goodwill. The equity consideration received by CMP members was calculated based on the negotiated price per share of common stock of the Company of $2.50, which approximated the quoted market price on the acquisition date. The contingent equity consideration (number of common shares) was also calculated based on the negotiated price per share of common stock of the Company of $2.50, which approximated the quoted market price. The total preliminary acquisition consideration used in preparing the consolidated financial statements is as follows: Acquisition Consideration: May 1, 2017 Measurement November 30, (As initially reported) Period Adjustments (1) 2017 (As adjusted) Cash $ 1,500,000 $ — $ 1,500,000 Fair value of common shares issued to CMP members 19,500,000 — 19,500,000 Promissory notes 660,216 6,572 333,393 Estimated fair value contingent cash consideration 1,735,375 169,625 1,905,000 Estimated fair value contingent equity consideration 10,763,760 1,088,640 11,852,400 Total estimated acquisition consideration $ 34,159,351 $ 1,264,837 $ 35,090,793 (1) As of August 31, 2017, the Company revised its estimate of the contingent cash consideration from $1,735,375 to $1,905,000, and the Company revised its estimate of the contingent equity consideration from $10,763,760 to $11,852,400, to reflect the increased probability of the sellers of CMP reaching the maximum earnouts available. An additional post-closing adjustment of $6,572 was recorded, which resulted in an increase of the promissory notes from $660,216 to $666,788. The balance of the note payable at November 30, 2017 reflects principal payments of $333,395 made to the sellers of CMP. |
CONCENTRATIONS OF RISK
CONCENTRATIONS OF RISK | 3 Months Ended |
Nov. 30, 2017 | |
Risks and Uncertainties [Abstract] | |
CONCENTRATIONS OF RISK | NOTE 3 – CONCENTRATIONS OF RISK Supplier Concentrations The Company purchases inventory from various suppliers and manufacturers. For the three months ended November 30, 2017 and 2016, two vendors, Transpring and Shenzhen Buddy Technology Co. Ltd., accounted for approximately 30% and 13%, respectively, of total inventory purchases. Customer Concentrations During the three months ended November 30, 2017 there was one customer which represented over 10% of the Company’s revenues there were no such customers for the same period ended November 30, 2016. As of November 30, 2017, there were two customers who represented 26% of accounts receivable. As of November 30, 2017, there was one customer that accounted for over 10% of accounts receivable. |
RELATED-PARTY TRANSACTIONS
RELATED-PARTY TRANSACTIONS | 3 Months Ended |
Nov. 30, 2017 | |
Related Party Transactions [Abstract] | |
RELATED-PARTY TRANSACTIONS | NOTE 4 – RELATED-PARTY TRANSACTIONS The Company leases its California and Colorado facilities from related parties. During the three months ended November 30, 2017 and 2016, the Company made rent payments of $53,660 and $50,700, respectively, to these related parties. |
PROPERTY AND EQUIPMENT
PROPERTY AND EQUIPMENT | 3 Months Ended |
Nov. 30, 2017 | |
Property, Plant and Equipment [Abstract] | |
PROPERTY AND EQUIPMENT | NOTE 5 – PROPERTY AND EQUIPMENT The major classes of fixed assets consist of the following as of November 30, 2017 and August 31, 2017: November 30, August 31, 2017 2017 Machinery and equipment $ 887,203 $ 886,608 Vehicles 144,845 144,845 Office Equipment 130,085 118,387 Leasehold improvements 107,832 71,545 1,269,965 1,221,385 Accumulated Depreciation (345,093 ) (289,622 ) $ 924,872 $ 931,763 Depreciation expense was $55,472 and $29,510, for the three months ended November 2017 and 2016, respectively. Of the $55,472 of depreciation expense, $13,696 is included in depreciation and amortization expense and $41,776 is included in cost of goods sold on the consolidated statements of operations. |
INTANGIBLE ASSETS
INTANGIBLE ASSETS | 3 Months Ended |
Nov. 30, 2017 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
INTANGIBLE ASSETS | NOTE 6 – INTANGIBLE ASSETS On May 3, 2017, pursuant to an Asset Purchase Agreement between the Company and RUB Acquisition, LLC (“Seller”), the Company acquired the domain name and inventory for $150,000 in cash and 200,000 shares of restricted common stock having a fair value of $466,000. During the one-year period following the closing, the Seller may become entitled to receive up to an additional $100,000 in cash and 400,000 shares of common stock of the Company if certain contingent milestones are achieved. The Company accounted for the contingent consideration based upon a probability-weighted assessment of the occurrence of triggering events outlined in the asset purchase agreement. The Company initially recorded a preliminary contingent liability for the contingent cash consideration of $50,000 and recorded contingent equity consideration of $466,000. As of August 31, 2017, management determined that the probability of the Seller receiving the contingent earnout payments was remote. As a result and pursuant to guidance in ASC Topic 360-10-30-1 and Topic 450-20-25-2, the Company reduced the basis of the intangible asset by $516,000 to reflect these change of events. The fair value of the equity consideration issued at closing and the fair value of the contingent equity consideration was based on the closing price of the Company’s stock on May 3, 2017, which was $2.33. The total acquisition consideration used in preparing the consolidated financial statements is as follows: Asset Acquisition Consideration: Cash $ 150,000 Fair value of common shares issued to seller 466,000 Total estimated acquisition consideration $ 616,000 The following table summarizes the allocation of the fair values of the assets acquired: Inventory $ 26,716 Finite-lived intangible assets: Domain name 589,284 Net assets acquired 616,000 Total fair value of consideration $ 616,000 As a result of the acquisition of CMP Wellness, LLC, on May 1, 2017, the Company identified an intangible asset of $2,600,000 relating to the CMP trade name acquired and $800,000 relating to non-compete agreement. Intangible assets consist of the following: Weighted Average As of November 30, 2017 As of November 30, 2016 Estimated Gross Gross Useful Carrying Accumulated Carrying Accumulated Acquisition Description Life Value Amortization Value Amortization Roll-Uh-Bowl Domain name 5 years $ 589,284 $ (77,350 ) $ — $ — CMP Wellness, LLC Trade name 6 years 2,600,000 (252,777 ) — — Non-compete agreement 4 years 800,000 (116,667 ) — — $ 3,989,284 $ (446,794 ) $ — $ — The Company operates as one reporting segment. The Company determined that the web domain has an estimated useful life of five (5) years. The Company determined that the trade name has an estimated useful life of six (6) years and the non-compete has an estimated useful life of four (4) years. Amortization expense related to domain name, trade name and non-competition agreement is classified as a component of amortization of acquired intangible assets in the accompanying consolidated statement of operations. Accordingly, amortization expense of $188,118 was recorded for the three months ended November 30, 2017. |
ACCRUED EXPENSES AND OTHER CURR
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES | 3 Months Ended |
Nov. 30, 2017 | |
Accrued Liabilities and Other Liabilities [Abstract] | |
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES | NOTE 7 – ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES Accrued expenses and other current liabilities consist of the following: November 30, August 31, 2017 2017 Customer deposits $ 710,063 $ 342,909 Accrued compensation 189,748 245,975 Income tax payable 273,497 219,082 Credit card liabilities 51,854 142,157 Deferred rent 25,301 25,881 Sales tax payable 13,591 17,182 $ 1,264,054 $ 993,186 |
NOTES PAYABLE
NOTES PAYABLE | 3 Months Ended |
Nov. 30, 2017 | |
Debt Disclosure [Abstract] | |
NOTES PAYABLE | NOTE 8 – NOTES PAYABLE As partial consideration for the acquisition of CMP, the Company issued the sellers unsecured promissory notes totaling $770,820. Management has estimated that the post-closing working capital adjustments amounted to $104,032, which resulted in a decrease of the unsecured promissory notes payable from $770,820 to $666,788. The promissory notes mature on May 1, 2018 and bear interest at an annual rate of 1.15%. The notes and accrued and unpaid interest are payable in quarterly installments beginning August 1, 2017. As of November 30, 2017, management has accrued for $1,438 of interest on the promissory notes, which is included in accrued expenses and other current liabilities. The principal balance of $ is recognized in the current portion of notes payable in the consolidated balance sheet as of , 2017. Principal payments of $333,394 were made during the quarter ended November 30, 2017. Automobile Contracts Payable The Company has entered into purchase contracts for its vehicles. The loans are secured by the vehicles and bear interest at an average interest rate of approximately 6% per annum. Future principal payments on these automobile contracts payable is summarized in the table below: Principal Year ended August 31, Due 2018 $ 20,483 2019 17,453 2020 10,679 2021 3,063 $ 51,678 |
LOAN AGREEMENT
LOAN AGREEMENT | 3 Months Ended |
Nov. 30, 2017 | |
Loan Agreement [Abstract] | |
LOAN AGREEMENT | NOTE 9 – LOAN AGREEMENT On November 16, 2017, we and KIM as borrowers, and all of our other subsidiaries, as credit parties, entered into a Loan and Security Agreement (the “Loan Agreement”) with Gerber Finance Inc., as lender (“Gerber”), effective as of November 6, 2017. The Loan Agreement provides a secured revolving credit facility (the “Revolving Line”) in an aggregate principal amount of up to $2.0 million at any time outstanding, of which $1,502,418 including accrued interest was outstanding on November 30 th |
STOCKHOLDERS' EQUITY
STOCKHOLDERS' EQUITY | 3 Months Ended |
Nov. 30, 2017 | |
Stockholders' Equity Note [Abstract] | |
STOCKHOLDERS' EQUITY | NOTE 10 – STOCKHOLDERS' EQUITY Preferred Stock The authorized preferred stock is 10,000,000 shares with a par value of $0.001. As of November 30, 2017 and August 31, 2017, the Company has no shares of preferred stock issued or outstanding. Common Stock The authorized common stock is 265,000,000 shares with a par value of $0.0 01. As of November 30, 2017 and August 31, 2017, 60,006,178 and 58,607,066 shares were issued and outstanding, respectively. During the three months ended November 30, 2017, the Company sold 1,363,674 shares of its common stock to investors in exchange for cash of $2,045,505. For the same period ended November 30, 2017 the Company collected $2,564,050 of cash in advance of issuing the related 1,709,366 shares in the subsequent period. This amount is reflected as stock payable in the Company’s financial statements at November 30, 2017. Share-based Compensation The Company recorded stock compensation expense of $381,743 and $115,244 for the three month periods ended November 30, 2017 and 2016, respectively, in connection with the issuance of shares of common stock and options to purchase common stock. During the three month period ended November 30, 2017, the Company issued 27,231 shares of common stock to consultants in exchange for $20,000 of services rendered and $34,077 of prepaid services, for a total of $54,077. The $34,077 of prepaid services is included in prepaid expenses on the condensed consolidated balance sheet of which $14,602 has been amortized as of November 30, 2017. Stock Options The Company’s 2016 Stock Incentive Plan (the Plan) was adopted on February 9, 2016. The Plan permits the grant of share options and shares to its employees and directors for up to 5,000,000 shares of common stock. The Company believes that such awards better align the interests of its employees with those of its shareholders. Option awards are generally granted with an exercise price equal to the market price of the Company's stock at the date of grant; those option awards generally vest based on three years of continuous service and have 10-year contractual terms. The Company estimates the fair value of share-based compensation utilizing the Black-Scholes option pricing model, which is dependent upon several variables such as the expected option term, expected volatility of our stock price over the expected option term, expected risk-free interest rate over the expected option term, expected dividend yield rate over the expected option term, and an estimate of expected forfeiture rates. The Company believes this valuation methodology is appropriate for estimating the fair value of stock options granted to employees and directors which are subject to ASC Topic 718 requirements. These amounts are estimates and thus may not be reflective of actual future results, nor amounts ultimately realized by recipients of these grants. The Company recognizes compensation on a straight-line basis over the requisite service period for each award. The following table summarizes the assumptions the Company utilized to record compensation expense for stock options granted during the three months ended and 2016: November 30, November 30, 2017 2016 Expected term (years) 1-4 1-4 Expected volatility 60 % 60 % Weighted-average volatility 60 % 60 % Risk-free interest rate 1.14%-1.97 % 0.85%-1.57 % Dividend yield 0 % 0 % Expected forfeiture rate 33 % 33 % The expected life is computed using the simplified method, which is the average of the vesting term and the contractual term. The expected volatility is based on management's analysis of historical volatility for comparable companies. The risk-free interest rate is based on the U.S. Treasury yields with terms equivalent to the expected term of the related option at the time of the grant. While the Company believes these estimates are reasonable, the compensation expense recorded would increase if the expected life was increased, a higher expected volatility was used, or if the expected dividend yield increased. During the three months ended November 30, 2017 and 2016, the Company issued 960,500 and 431,500 stock options, respectively, pursuant to the Company’s 2016 Stock Incentive Plan. A summary of the Company’s stock option activity during the three month period ended November 30, 2017 is presented below: Weighted Weighted Average Average Remaining Aggregate No. of Exercise Contractual Intrinsic Options Price Term Value Balance Outstanding, August 31, 2017 5,275,500 $ 1.73 8.0 years $ 917,610 Granted 960,500 $ 2.25 9.9 years — Exercised 10,000 $ 1.00 — — Forfeited 37,500 $ 1.83 — — Balance Outstanding, November 30, 2017 6,188,500 $ 1.81 8.8 years 6,389,845 Exercisable, November 30, 2017 1,999,000 $ 0.94 8.2 years 4,242,215 The weighted-average grant-date fair value of options granted during the three months ended November 30, 2017 and 2016 , was $2.25 and $1.83, respectively. The weighted-average grant-date fair value of options forfeited during the three months ended November 30, 2017 During the three months ended November 30, 2017, the Company issued 4,709 shares of common stock pursuant to cashless exercises of 10,000 stock options. A summary of the status of the Company’s non-vested options as of August 31, 2017, and changes during the three month period ended November 30, 2017, is presented below: Weighted Average No. of Grant-Date Options Fair Value Nonvested at August 31, 2017 3,679,972 $ 1,878,144 Granted 960,500 2,158,955 Exercised (10,000 ) 8,003 Vested (403,472 ) (92,902 ) Forfeited (37,500 ) (69,300 ) Nonvested at November 30, 2017 4,189,500 $ 4,260,701 As of November 30, 2017, there was $3,703,25 of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the Plan. That cost is expected to be recognized over a weighted-average period of 1.9 years. The total fair value of shares vested during the three month period November 30, 2017 is $214,031. This amount is included in stock compensation expense on the consolidated statements of operations. |
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 3 Months Ended |
Nov. 30, 2017 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS AND CONTINGENCIES | NOTE 11 – COMMITMENTS AND CONTINGENCIES Lease The Company’s corporate head-quarters and primary distribution center is located in Santa Ana, California. In July 2017, the Company entered into a facility lease in Garden Grove, California. The Garden Grove facility lease expires on August 1, 2022 and requires escalating monthly payments that range between $24,480 and $28,379. As part of the acquisition of CMP on May 1, 2017, the Company assumed the lease for CMP’s facility located in Lawndale, California. The lease expires in January 2019, and requires escalating monthly payments that range between $4,031 and $4,143. On April 1, 2016, the Company entered into a sublease agreement for a facility located in Woodinville, Washington. The lease commenced on July 15, 2016 and expires on January 31, 2020, and requires escalating monthly payments that range between $14,985 and $16,022. Effective April 10, 2015, the Company assumed the facility lease in Denver, Colorado, which is the headquarters of operations for its wholly-owned subsidiary, Dank. On September 1, 2016, the Colorado facility lease was amended to include additional office space. The lease runs through March 31, 2020 and requires escalating monthly payments, ranging between $4,800 and $7,300. During the three months ended November 30, 2017 and 2016, the Company recognized $160,093 and $94,418, respectively, of rental expense, related to its office, retail and warehouse space. The increase is the result of the addition of the CMP Wellness facility as well as expenses related to the Company’s new headquarters in Garden Grove, CA. Minimum future commitments under non-cancelable operating leases and other obligations were as follows: Year ended August 31, 2018 453,619 2019 601,102 2020 444,420 2021 322,604 2022 332,278 $ 2,154,023 CMP Wellness During the one-year period following the acquisition of CMP (see Note 2) the two sellers of the business may become entitled to receive up to an additional $1,820,000 in cash and 4,740,960 shares of common stock of the Company. The liability is based on the gross profit generated by CMP product line for the period from May 1, 2017 to April 30, 2018 as outlined in the acquisition agreement. Other Commitments In the ordinary course of business, the Company may enter into contractual purchase obligations and other agreements that are legally binding and specify certain minimum payment terms. The Company had no such agreements as of November 30, 2017 Litigation The Company may be subject to legal proceedings and claims which arise in the ordinary course of its business. Although occasional adverse decisions or settlements may occur, the Company believes that the final disposition of such matters should not have a material adverse effect on its financial position, results of operations or liquidity. The Company had no pending legal proceedings or claims as of November 30, 2017 |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 3 Months Ended |
Nov. 30, 2017 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | NOTE 12 – SUBSEQUENT EVENTS Subsequent to November 30, 2017 and through January 12, 2018, the Company issued 67,500 shares related to options exercised for $78,300 in cash. |
NATURE OF BUSINESS AND SIGNIF18
NATURE OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Policies) | 3 Months Ended |
Nov. 30, 2017 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Acquisition of CMP Wellness, LLC | Acquisition of CMP Wellness, LLC On May 1, 2017, the Company entered into an agreement of merger agreement with Lancer West Enterprises, Inc. a California corporation, Walnut Ventures, a California corporation, Jason Manasse, an individual, and Theodore Nicols, an individual, pursuant to which each of Lancer West Enterprises, Inc. and Walnut Ventures were merged with and into Merger Sub, with Merger Sub as the surviving corporation, resulting in the Company’s indirect acquisition of CMP Wellness, LLC, a California limited liability company, which prior to the merger, was owned 100% by Lancer West Enterprises, Inc. and Walnut Ventures. CMP Wellness, LLC is a distributor of vaporizers, cartridges and accessories. The acquisition was accounted for using the acquisition method of accounting in accordance with ASC 805, Business Combinations. The purchase price payable to Jason Manasse and Theodore Nicols at the closing of the merger in exchange for consummating the merger was comprised of an aggregate of $1,500,000 in cash, unsecured promissory notes in the aggregate principal amount of approximately $770,820, having a one-year maturity, and an aggregate of 7,800,000 restricted shares of the Company’s common stock. The purchase price is subject to customary post-closing adjustments with respect to confirmation of the levels of working capital and cash held by CMP Wellness, LLC as of the closing. During the one-year period following the closing, Jason Manasse and Theodore Nicols may become entitled to receive up to an additional approximately $1,905,000 in cash, in the aggregate, and approximately 4,740,960 shares of common stock of the Company, in the aggregate, based on the future performance of CMP Wellness, LLC (See Note 2). |
Basis of Presentation | Basis of Presentation The accompanying unaudited condensed consolidated financial statements and related notes include the activity of the Company and its wholly owned subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information. All intercompany balances and transactions have been eliminated. Accordingly, they do not include all of the information and notes required by generally accepted accounting principles for annual financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. Our operating results for the three month period ended November 30, 2017 are not necessarily indicative of the results that may be expected for the fiscal year ended August 31, 2018, or for any other period. These unaudited condensed consolidated financial statements and notes should be read in conjunction with the Company’s audited consolidated financial statements and accompanying notes for the fiscal year ended August 31, 2017. The condensed consolidated balance sheet as of August 31, 2017 included herein was derived from the audited financial statements as of that date, but does not include all disclosures including notes required by GAAP. There have been no changes to our significant accounting policies described in our Annual Report on Form 10-K for the fiscal year ended August 31, 2017 that have had a material impact on our condensed consolidated financial statements and related notes. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amount of revenues and expenses during the reporting period. Significant estimates relied upon in preparing these unaudited condensed consolidated financial statements include revenue recognition, accounts receivable reserves, inventory and related reserves, valuations and purchase price allocations related to business combinations, expected future cash flows used to evaluate the recoverability of long-lived assets, estimated fair values of long-lived assets used to record impairment charges related to intangible assets and goodwill, amortization periods, accrued expenses, stock-based compensation, and recoverability of the Company’s net deferred tax assets and any related valuation allowance. Although the Company regularly assesses these estimates, actual results could differ materially from these estimates. Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances. Actual results may differ from management’s estimates if past experience or other assumptions do not turn out to be substantially accurate. The Company is subject to a number of risks similar to those of other companies of similar size and having a focus of serving the cannabis industry, including, the development stage of certain products, competition, limited number of suppliers, integration of acquisitions, substantial indebtedness, government regulations, protection of proprietary rights, and dependence on key individuals. |
Segments | Segments The Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial information is evaluated regularly by the chief operating decision maker, who is the chief executive officer, in deciding how to allocate resources and assessing performance. Over the past few years, the Company has completed a number of acquisitions. These acquisitions have allowed the Company to expand its offerings, presence and reach in the cannabis industry. While the Company has offerings in multiple geographic locations for its products for the cannabis industry, including as a result of the Company's acquisitions, the Company’s business operates in one operating segment because the majority of the Company's offerings operate similarly, and the Company’s chief operating decision maker evaluates the Company’s financial information and resources and assesses the performance of these resources on a consolidated basis. Since the Company operates in one operating segment, all required financial segment information can be found in the unaudited condensed consolidated financial statements. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers cash and cash equivalents to consist of cash on hand and investments having an original maturity of 90 days or less that are readily convertible into cash. The Company invests its cash and cash equivalents with financial institutions with highly rated credit and monitors the amount on deposit at the financial institution. As of November 30, 2017 and August 31, 2017, the Company had $5,549,431 and $916,984 respectively. |
Accounts Receivable | Accounts Receivable Trade accounts receivable are carried at their estimated collectible amounts. Trade credit is generally extended on a short-term basis, thus trade receivables do not bear interest. Trade accounts receivables are periodically evaluated for collectability based on past credit history and their current financial condition. The Company’s allowance for doubtful accounts was $40,478 and $25,000 as of November 30, 2017 and August 31, 2017, respectively. |
Inventory | Inventory Inventories are stated at the lower of cost or net realizable value using the first-in first out (FIFO) method. The Company’s inventory consists of finished goods of $3,850,678 and $3,754,171 as of November 30, 2017 and August 31, 2017, respectively. |
Property and Equipment | Property and Equipment Property and equipment is recorded at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the shorter of estimated useful life of the asset or the lease term, after the asset is placed in service. The estimated useful lives of the property and equipment are generally as follows: computer software acquired for internal use, three to seven years; computer equipment, two to three years; leasehold improvements, three to life of lease; and furniture and equipment, one to 7 years. Gains and losses from the retirement or disposition of property and equipment are included in operations in the period incurred. Maintenance and repairs are expensed as incurred. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The fair value of certain of our financial instruments, including cash and cash equivalents, receivables, other current assets, accounts payable, accrued compensation and employee benefits, other accrued liabilities and notes payable, approximate their carrying amounts because of the short-term maturity of these instruments. |
Concentration of Risk | Concentration of Risk The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, and accounts receivable. Collateral is not required for accounts receivable. The Company maintains an allowance for its doubtful accounts receivable. This allowance is based upon historical loss patterns, the number of days that billings are past due and an evaluation of the potential risk of loss associated with delinquent accounts. Receivables are written-off and charged against its recorded allowance when the Company has exhausted collection efforts without success. The Company’s losses related to collection of trade receivables have consistently been within management’s expectations. Due to these factors, no additional credit risk beyond amounts provided for collection losses, which the Company reevaluates on a monthly basis based on specific review of receivable aging and the period that any receivables are beyond the standard payment terms, is believed by management to be probable in the Company’s accounts receivable. Although, the Company is directly affected by the overall financial condition of the cannabis industry, management does not believe significant credit risk exists as of November 30, 2017. The Company generally has not experienced any material losses related to receivables from individual customers or groups of customers. The Company maintains an allowance for doubtful accounts based on accounts past due according to contractual terms and historical collection experience. Actual losses when incurred are charged to the allowance. The Company purchases products from a small number of suppliers. A change in or loss of these suppliers could cause a delay in filling customer orders and a possible loss of sales, which would adversely affect results of operations; however, management believes that suitable replacement suppliers could be obtained in such an event. |
Intangible Assets acquired through Business Combinations | Intangible Assets acquired through Business Combinations Intangible assets, domain name, trademarks and non-compete agreements that are deemed to have a definite life are amortized over their estimated useful lives and intangible assets with an indefinite life are assessed for impairment at least annually. Each period, the Company evaluates the estimated remaining useful life of its intangible assets and whether events or changes in circumstances warrant a revision to the remaining period of amortization. |
Impairment Assessment | Impairment Assessment The Company evaluates intangible assets and long-lived assets for possible impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. This includes but is not limited to significant adverse changes in business climate, market conditions, or other events that indicate an asset's carrying amount may not be recoverable. Recoverability of these assets is measured by comparison of the carrying amount of each asset to the future undiscounted cash flows the asset is expected to generate. If the undiscounted cash flows used in the test for recoverability are less than the carrying amount of these assets, the carrying amount of such assets is reduced to fair value. The Company evaluates and tests the recoverability of its goodwill for impairment at least annually during its fourth quarter of each fiscal year or more often if and when circumstances indicate that goodwill may not be recoverable. There was no impairment of intangible assets, long-lived assets or goodwill during the three months ended November 30, 2017 and for the fiscal year ended August 31, 2017. |
Valuation of Business Combinations and Acquisition of Intangible Assets | Valuation of Business Combinations and Acquisition of Intangible Assets The Company records intangible assets acquired in business combinations and acquisitions of intangible assets under the purchase method of accounting. The Company accounts for acquisitions in accordance with FASB ASC Topic 805, Business Combinations The Company uses the income approach, the relief from royalty method (both a market and income method), and the with and without method to determine the fair values of its purchased intangible assets. The Company uses the probability-weighted expected return method (an income approach) to determine the appropriate amount of contingent consideration to include in the purchase price for an acquisition. The Company bases its revenue assumptions on estimates of relevant market sizes, expected market growth rates, expected industry trends and expected product introductions by competitors. In arriving at the value. The Company bases the discount rate used to arrive at a present value as of the date of acquisition on the time value of money and cannabis industry investment risk factors. For the intangible assets acquired, the Company used risk-adjusted discount rates ranging from 19% to 26% to discount its projected cash flows. The Company believes that the estimated purchased intangible asset amounts so determined represent the fair value at the date of acquisition and do not exceed the amount a third party would pay for the projects. The Company also used the income approach (probably weighted cash flow), as described above, to determine the estimated fair value of certain identifiable intangibles assets including domain names and tradenames. Domain names represent established relationships with customers, which provides a ready channel for the sale of additional products and services. Tradenames represent acquired product names that the Company intends to continue to utilize. The Company used the with and without method to ascertain the fair value of the non-competition agreement. |
Goodwill and Intangible Assets | Goodwill and Intangible Assets Goodwill and intangible assets that have indefinite useful lives are not amortized but are evaluated for impairment annually or whenever events or changes in circumstances indicate that the carrying value may not be recoverable. The Company records intangible assets at historical cost. The Company amortizes its intangible assets that have finite lives using either the straight-line method or based on estimated future cash flows to approximate the pattern in which the economic benefit of the asset will be utilized. Amortization is recorded over the estimated useful lives ranging from four to six years. The Company reviews intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life. Conditions that would indicate impairment and trigger a more frequent impairment assessment include, but are not limited to, a significant adverse change in legal factors or business climate that could affect the value of an asset, or an adverse action or assessment by a regulator. If the carrying value of an asset exceeds its undiscounted cash flows, the Company will write-down the carrying value of the intangible asset to its fair value in the period identified. The Company generally calculates fair value as the present value of estimated future cash flows to be generated by the asset using a risk-adjusted discount rate. If the estimate of an intangible asset’s remaining useful life is changed, the Company will amortize the remaining carrying value of the intangible asset prospectively over the revised remaining useful life. Consistent with prior years, the Company conducted its annual impairment test of goodwill during the fourth quarter of fiscal 2017. The estimate of fair value requires significant judgment. Any loss resulting from an impairment test would be reflected in operating income in the Company’s unaudited condensed consolidated statements of income. The annual impairment testing process is subjective and requires judgment at many points throughout the analysis. If these estimates or their related assumptions change in the future, the Company may be required to record impairment charges for these assets not previously recorded. |
Business Combinations | Business Combinations The Company uses its best estimates and assumptions to accurately assign fair value to the tangible and intangible assets acquired and liabilities assumed at the acquisition date. The Company’s estimates are inherently uncertain and subject to refinement. During the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments to the fair value of these tangible and intangible assets acquired and liabilities assumed, with the corresponding offset to goodwill. In addition, uncertain tax positions and tax-related valuation allowances are initially established in connection with a business combination as of the acquisition date. The Company continues to collect information and reevaluates these estimates and assumptions quarterly and records any adjustments to the Company’s preliminary estimates to goodwill provided that the Company is within the measurement period. Upon the conclusion of the measurement period or final determination of the fair value of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the Company’s condensed consolidated statements of operations. |
Earnings (Loss) Per Share | Earnings (Loss) Per Share The Company computes earnings per share under Accounting Standards Codification subtopic 260-10, "Earnings per Share" (“ASC 260-10”). Basic net income (loss) per common share is computed by dividing net loss by the weighted average number of shares of common stock. Diluted net loss per share is computed using the weighted average number of common and common stock equivalent shares outstanding during the period. Basic earnings per share are computed by dividing net earnings by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share are computed by dividing net earnings by the sum of (a) the weighted average number of shares of common stock outstanding during the period and (b) the potentially dilutive securities outstanding during the period. Stock options are potentially dilutive securities; and the number of dilutive options is computed using the treasury stock method. The effect of the contingent equity consideration relating to the acquisition of CMP is also factored into the calculation of dilutive securities. The following table sets forth the calculation of basic and diluted earnings per share: Three months ended November 30, November 30, 2017 2016 Net income (loss) $ 94,615 $ (161,958 ) Weighted average common shares outstanding for basic EPS 59,194,323 48,713,496 Net effect of dilutive options 1,973,085 1,797,803 Net effect of contingent equity consideration 4,740,960 — Weighted average common shares outstanding for diluted EPS 65,908,368 50,511,299 Basic earnings (loss) per share $ 0.00 $ (0.00 ) Diluted earnings (loss) per share $ 0.00 $ (0.00 ) |
Comprehensive Income (loss) | Comprehensive Income (loss) Comprehensive income (loss) is the change in the Company’s equity (net assets) during each period from transactions and other events and circumstances from non-owner sources. During the quarters ended November 30, 2017 and 2016, the Company had no elements of comprehensive income or loss. |
Revenue Recognition | Revenue Recognition It is the Company’s policy that revenues from product sales is recognized in accordance with ASC 605 "Revenue Recognition". Four basic criteria must be met before revenue can be recognized; (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management’s judgments regarding fixed nature in selling prices of the products delivered and the collectability of those amounts. The Company has not implemented any specific rebate programs. Provisions for discounts to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. During the three month period ended November 30, 2017 and 2016, we had no provisions for sales discounts of $0 and $19,457, respectively. The Company has not established a formal customer incentive program, but considers and accommodates discounts to certain customers on a case by case basis, including by way of example, for volume shipping or for certain new customers with orders over a specific discretionary dollar threshold. The Company classifies the reimbursement by customers of shipping and handling costs as revenue and the associated cost as cost of revenue. As of November 30, 2017 and, 2016, the Company had a refund allowance of $0 and $0, respectively. Consistent with ASC 605-15-25-1, the Company considers factors such as historical return of products, estimated remaining shelf life, price changes from competitors, and introductions of competing products in establishing a refund allowance. The Company recognizes revenues as risk and title to products transfers to the customer (which generally occurs at the time shipment is made), the sales price is fixed or determinable, and collectability is reasonably assured. The Company defers any revenue for which the product was not delivered or is subject to refund until such time that the Company and the customer jointly determine that the product has been delivered or no refund will be required. |
Warranty Costs | Warranty Costs The Company has not had any historical warranty related expenditures from the sales of its products, which if incurred would result in the return of any defective products by customers |
Share-based Compensation | Share-based Compensation The Company account for its stock based award in accordance with Accounting Standards Codification subtopic 718-10, "Compensation", which requires fair value measurement and recognition of compensation expense for all share-based payment awards made to employees and directors, including restricted stock awards. The Company estimates the fair value of stock using the stock price on the date of the approval of the award. The fair value is then expensed over the requisite service periods of the awards, which is generally the performance period and the related amount is recognized in the consolidated statements of operations. |
Advertising | Advertising The Company conducts advertising for the promotion of its products and services. In accordance with ASC Topic 720-35-25, advertising costs are charged to operations when incurred. |
Income Taxes | Income Taxes The Company accounts for income taxes in accordance with accounting guidance now codified as FASB ASC 740, "Income Taxes," which requires that the Company recognize deferred tax liabilities and assets based on the differences between the financial statement carrying amounts and the tax bases of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse. Deferred income tax benefit (expense) results from the change in net deferred tax assets or deferred tax liabilities. A valuation allowance is recorded when it is more likely than not that some or all deferred tax assets will not be realized. The Company applies the provisions of ASC 740, "Accounting for Uncertainty in Income Taxes". The ASC prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The ASC provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. The Company utilizes a two-step approach to recognizing and measuring uncertain tax positions (tax contingencies). The first step evaluates the tax position for recognition by determining if the weight of available evidence indicates it is more likely than not that we will sustain the position on audit, including resolution of related appeals or litigation processes. The second step measures the tax benefit as the largest amount more than 50% likely of being realized upon ultimate settlement. The Company did not identify any material uncertain tax positions on returns that have been filed or that will be filed. The Company did not recognize any interest or penalties for unrecognized tax benefits during the three month ended November 30, 2017 and the fiscal year ended August 31, 2017, nor were any interest or penalties accrued as of November 30, 2017 and August 31, 2016. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The Company adopted ASC 820 which defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). The standard outlines a valuation framework and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements and the related disclosures. Under this standard certain assets and liabilities must be measured at fair value, and disclosures are required for items measured at fair value The Company currently does not have non-financial assets or non-financial liabilities that are required to be measured at fair value on a recurring basis. The Company’s financial assets and liabilities are measured using inputs from the three levels of the fair value hierarchy. The three levels are as follows Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. The fair value of the Company’s cash is based on quoted prices and therefore classified as Level 1 Level 2 - Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates, yield curves, etc.), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs) Level 3 - Unobservable inputs that reflect management’s assumptions about the assumptions that market participants would use in pricing the asset or liability Application of Valuation Hierarchy Financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The following is a description of the valuation methodology used to measure fair value, as well as the general classification of such instruments pursuant to the valuation hierarchy The Company has a contingent consideration liability of $1,820,000, which consists of contingent cash consideration of $1,820,000 resulting from the acquisition of CMP (Note 2). The contingent consideration liability is calculated based on the weighted average probability of meeting certain milestones. This liability is remeasured at each reporting period. The Company had no other financial assets or liabilities that are measured at fair value on a recurring basis as of November 30, 2017 The following table summarizes, for assets or liabilities measured at fair value, the respective fair value and the classification by level of input within the fair value hierarchy: Fair Value Measurement at Reporting Date Using Description November 30, 2017 Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Contingent consideration liability $ 1,820,000 $ — $ — $ 1,820,000 The Company classifies its contingent consideration liability within Level 3 as the valuation inputs are based on quoted market prices and market observable data. During the three months ended November 30, 2017, the Company did not recognize any change in the fair value of its contingent consideration liability of $1,820,000. |
Recently Issued Accounting Pronouncements | Recently Issued Accounting Pronouncements In September 2017, the FASB issued Accounting Standards Update (ASU) No. 2017-13, “Revenue Recognition (Topic 605), Revenue from Contracts with Customers (Topic 606), Leases (Topic 840), and Leases (Topic 842): Amendments to SEC Paragraphs Pursuant to the Staff Announcement at the July 20, 2017 EITF Meeting and Rescission of Prior SEC Staff Announcements and Observer Comments.” In January 2017, the FASB issued Accounting Standards Update No. 2017-04, Simplifying the Test for Goodwill Impairment In January 2017, the FASB issued Accounting Standards Update No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business In August, 2016, the FASB issued Accounting Standards Update No. 2016-15, Classification of Certain Cash Receipts and Cash Payments (a consensus of the Emerging Issues Task Force) Statement of Cash Flows In May 2016, accounting guidance was issued to clarify the not yet effective revenue recognition guidance issued in May 2014. This additional guidance does not change the core principle of the revenue recognition guidance issued in May 2014, rather, it provides clarification of accounting for collections of sales taxes as well as recognition of revenue (i) associated with contract modifications, (ii) for noncash consideration, and (iii) based on the collectability of the consideration from the customer. The guidance also specifies when a contract should be considered “completed” for purposes of applying the transition guidance. The effective date and transition requirements for this guidance are the same as the effective date and transition requirements for the guidance previously issued in 2014, which is effective for interim and annual periods beginning on or after December 15, 2017. The new standard also permits two methods of adoption: retrospectively to each prior reporting period presented (full retrospective method), or retrospectively with the cumulative effect of initially applying the guidance recognized at the date of initial application (the modified retrospective method). The Company’s management currently anticipates adopting the standard using the modified retrospective method. While management is still in the process of completing the analysis on the impact this guidance will have on the Company’s consolidated financial statements, related disclosures, and its internal controls over financial reporting. The Company has not yet determined whether the impact that this new guidance will be material to its consolidated financial statements. In March 2016, the FASB issued ASU 2016-09, Compensation—Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) In January 2016, the FASB issued ASU 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities Other Accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the consolidated financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures. |
NATURE OF BUSINESS AND SIGNIF19
NATURE OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Tables) | 3 Months Ended |
Nov. 30, 2017 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Schedule of basic and diluted earnings per share | Three months ended November 30, November 30, 2017 2016 Net income (loss) $ 94,615 $ (161,958 ) Weighted average common shares outstanding for basic EPS 59,194,323 48,713,496 Net effect of dilutive options 1,973,085 1,797,803 Net effect of contingent equity consideration 4,740,960 — Weighted average common shares outstanding for diluted EPS 65,908,368 50,511,299 Basic earnings (loss) per share $ 0.00 $ (0.00 ) Diluted earnings (loss) per share $ 0.00 $ (0.00 ) |
Schedule of assets or liabilities measured at fair value | Fair Value Measurement at Reporting Date Using Description November 30, 2017 Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Contingent consideration liability $ 1,820,000 $ — $ — $ 1,820,000 |
ACQUISITION OF CMP WELLNESS, 20
ACQUISITION OF CMP WELLNESS, LLC (Tables) | 3 Months Ended |
Nov. 30, 2017 | |
Business Acquisition, Pro Forma Information [Abstract] | |
Schedule of acquisition consideration | Acquisition Consideration: May 1, 2017 Measurement November 30, (As initially reported) Period Adjustments (1) 2017 (As adjusted) Cash $ 1,500,000 $ — $ 1,500,000 Fair value of common shares issued to CMP members 19,500,000 — 19,500,000 Promissory notes 660,216 6,572 333,393 Estimated fair value contingent cash consideration 1,735,375 169,625 1,905,000 Estimated fair value contingent equity consideration 10,763,760 1,088,640 11,852,400 Total estimated acquisition consideration $ 34,159,351 $ 1,264,837 $ 35,090,793 (1) As of August 31, 2017, the Company revised its estimate of the contingent cash consideration from $1,735,375 to $1,905,000, and the Company revised its estimate of the contingent equity consideration from $10,763,760 to $11,852,400, to reflect the increased probability of the sellers of CMP reaching the maximum earnouts available. An additional post-closing adjustment of $6,572 was recorded, which resulted in an increase of the promissory notes from $660,216 to $666,788. The balance of the note payable at November 30, 2017 reflects principal payments of $333,395 made to the sellers of CMP. |
PROPERTY AND EQUIPMENT (Tables)
PROPERTY AND EQUIPMENT (Tables) | 3 Months Ended |
Nov. 30, 2017 | |
Property, Plant and Equipment [Abstract] | |
Schedule of property, plant and equipment | November 30, August 31, 2017 2017 Machinery and equipment $ 887,203 $ 886,608 Vehicles 144,845 144,845 Office Equipment 130,085 118,387 Leasehold improvements 107,832 71,545 1,269,965 1,221,385 Accumulated Depreciation (345,093 ) (289,622 ) $ 924,872 $ 931,763 |
INTANGIBLE ASSETS (Tables)
INTANGIBLE ASSETS (Tables) | 3 Months Ended |
Nov. 30, 2017 | |
Intangible Assets Disclosure [Abstract] | |
Schedule of asset acquisition consideration | Asset Acquisition Consideration: Cash $ 150,000 Fair value of common shares issued to seller 466,000 Total estimated acquisition consideration $ 616,000 |
Schedule of allocation of the fair values of the assets acquired | Inventory $ 26,716 Finite-lived intangible assets: Domain name 589,284 Net assets acquired 616,000 Total fair value of consideration $ 616,000 |
Schedule of intangible assets | Weighted Average As of November 30, 2017 As of November 30, 2016 Estimated Gross Gross Useful Carrying Accumulated Carrying Accumulated Acquisition Description Life Value Amortization Value Amortization Roll-Uh-Bowl Domain name 5 years $ 589,284 $ (77,350 ) $ — $ — CMP Wellness, LLC Trade name 6 years 2,600,000 (252,777 ) — — Non-compete agreement 4 years 800,000 (116,667 ) — — $ 3,989,284 $ (446,794 ) $ — $ — |
ACCRUED EXPENSES AND OTHER CU23
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables) | 3 Months Ended |
Nov. 30, 2017 | |
Accrued Liabilities and Other Liabilities [Abstract] | |
Schedule of accrued liabilities | November 30, August 31, 2017 2017 Customer deposits $ 710,063 $ 342,909 Accrued compensation 189,748 245,975 Income tax payable 273,497 219,082 Credit card liabilities 51,854 142,157 Deferred rent 25,301 25,881 Sales tax payable 13,591 17,182 $ 1,264,054 $ 993,186 |
NOTES PAYABLE (Tables)
NOTES PAYABLE (Tables) | 3 Months Ended |
Nov. 30, 2017 | |
Debt Disclosure [Abstract] | |
Schedule of notes payable | Principal Year ended August 31, Due 2018 $ 20,483 2019 17,453 2020 10,679 2021 3,063 $ 51,678 |
STOCKHOLDERS' EQUITY (Tables)
STOCKHOLDERS' EQUITY (Tables) | 3 Months Ended |
Nov. 30, 2017 | |
Stockholders' Equity Note [Abstract] | |
Schedule of assumptions used | November 30, November 30, 2017 2016 Expected term (years) 1-4 1-4 Expected volatility 60 % 60 % Weighted-average volatility 60 % 60 % Risk-free interest rate 1.14%-1.97 % 0.85%-1.57 % Dividend yield 0 % 0 % Expected forfeiture rate 33 % 33 % |
Schedule of stock option activity | Weighted Weighted Average Average Remaining Aggregate No. of Exercise Contractual Intrinsic Options Price Term Value Balance Outstanding, August 31, 2017 5,275,500 $ 1.73 8.0 years $ 917,610 Granted 960,500 $ 2.25 9.9 years — Exercised 10,000 $ 1.00 — — Forfeited 37,500 $ 1.83 — — Balance Outstanding, November 30, 2017 6,188,500 $ 1.81 8.8 years 6,389,845 Exercisable, November 30, 2017 1,999,000 $ 0.94 8.2 years 4,242,215 |
Schedule of nonvested share activity | Weighted Average No. of Grant-Date Options Fair Value Nonvested at August 31, 2017 3,679,972 $ 1,878,144 Granted 960,500 2,158,955 Exercised (10,000 ) 8,003 Vested (403,472 ) (92,902 ) Forfeited (37,500 ) (69,300 ) Nonvested at November 30, 2017 4,189,500 $ 4,260,701 |
COMMITMENTS AND CONTINGENCIES (
COMMITMENTS AND CONTINGENCIES (Tables) | 3 Months Ended |
Nov. 30, 2017 | |
Commitments and Contingencies Disclosure [Abstract] | |
Schedule of minimum future commitments | Year ended August 31, 2018 453,619 2019 601,102 2020 444,420 2021 322,604 2022 332,278 $ 2,154,023 |
NATURE OF BUSINESS AND SIGNIF27
NATURE OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Calculation of basic and diluted earnings per share (Details) - USD ($) | 3 Months Ended | |
Nov. 30, 2017 | Nov. 30, 2016 | |
Accounting Policies [Abstract] | ||
Net income (loss) | $ 94,615 | $ (161,958) |
Weighted average common shares outstanding for basic EPS (in shares) | 59,194,323 | 48,713,496 |
Net effect of dilutive options | 1,973,085 | 1,797,803 |
Net effect of contingent equity consideration | 4,740,960 | 0 |
Weighted average common shares outstanding for diluted EPS | 65,908,368 | 50,511,299 |
Basic earnings (loss) per share (in dollars per share) | $ 0 | $ 0 |
Diluted earnings (loss) per share (in dollars per share) | $ 0 | $ 0 |
NATURE OF BUSINESS AND SIGNIF28
NATURE OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Fair value and classification by level of input (Details 1) - Fair Value | 3 Months Ended |
Nov. 30, 2017USD ($) | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Contingent consideration liability | $ 1,820,000 |
Quoted Prices in Active Markets for Identical Assets (Level 1) | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Contingent consideration liability | 0 |
Significant Other Observable Inputs (Level 2) | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Contingent consideration liability | 0 |
Significant Unobservable Inputs (Level 3) | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Contingent consideration liability | $ 1,820,000 |
NATURE OF BUSINESS AND SIGNIF29
NATURE OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Detail Textuals) | May 01, 2017USD ($)shares | May 01, 2017USD ($) | Mar. 04, 2014shares | Nov. 30, 2017USD ($)Segmentshares | Nov. 30, 2016USD ($) | Nov. 30, 2017USD ($) | Aug. 31, 2017USD ($) | Aug. 31, 2016USD ($) |
Nature Of Business And Significant Accounting Policies [Line Items] | ||||||||
Cash consideration | $ 150,000 | $ 1,500,000 | ||||||
Unsecured promissory note principal amount | $ 770,820 | 770,820 | ||||||
Sales discounts | 0 | $ 19,457 | ||||||
Revenue recognition, refund allowances | $ 0 | 0 | ||||||
Number of operating segment | Segment | 1 | |||||||
Cash and cash equivalents | $ 5,549,431 | $ 2,000,439 | 5,549,431 | $ 916,984 | $ 1,027,003 | |||
Allowance for doubtful accounts | 40,478 | 40,478 | 25,000 | |||||
Inventory finished goods | $ 3,850,678 | 3,850,678 | $ 3,754,171 | |||||
Estimated fair value contingent cash consideration | $ 1,905,000 | |||||||
Number of stock issued to investor in exchange for cash | shares | 1,363,674 | |||||||
Risk-adjusted discount rates | 19% to 26% | |||||||
Computer software | ||||||||
Nature Of Business And Significant Accounting Policies [Line Items] | ||||||||
Property and equipment, estimated useful life | three to seven years | |||||||
Computer equipment | ||||||||
Nature Of Business And Significant Accounting Policies [Line Items] | ||||||||
Property and equipment, estimated useful life | two to three years | |||||||
Leasehold improvements | ||||||||
Nature Of Business And Significant Accounting Policies [Line Items] | ||||||||
Property and equipment, estimated useful life | three to life of lease | |||||||
Furniture and equipment | ||||||||
Nature Of Business And Significant Accounting Policies [Line Items] | ||||||||
Property and equipment, estimated useful life | one to 7 years | |||||||
Fair Value | ||||||||
Nature Of Business And Significant Accounting Policies [Line Items] | ||||||||
Contingent consideration liability | $ 1,820,000 | |||||||
Lancer West Enterprises, Inc And Walnut Ventures | ||||||||
Nature Of Business And Significant Accounting Policies [Line Items] | ||||||||
Limited liability company percentage | 100.00% | |||||||
CMP Wellness | ||||||||
Nature Of Business And Significant Accounting Policies [Line Items] | ||||||||
Cash consideration | $ 1,500,000 | $ 1,820,000 | ||||||
Unsecured promissory note principal amount | $ 770,820 | $ 770,820 | ||||||
Number of aggregate restricted shares | shares | 7,800,000 | |||||||
Estimated fair value contingent cash consideration | $ 1,905,000 | |||||||
Number of stock issued to investor in exchange for cash | shares | 4,740,960 | |||||||
KIM International Corporation (KIM) | ||||||||
Nature Of Business And Significant Accounting Policies [Line Items] | ||||||||
Shares exchanged for common stock | shares | 32,400,000 | |||||||
Shares exchanged | shares | 10,000 |
ACQUISITION OF CMP WELLNESS, 30
ACQUISITION OF CMP WELLNESS, LLC - Acquisition consideration (Details) - USD ($) | May 01, 2017 | Nov. 30, 2017 | |
Business Acquisition [Line Items] | |||
Cash | $ 150,000 | $ 1,500,000 | |
Fair value of common shares issued to CMP members | 19,500,000 | ||
Promissory notes | 333,393 | ||
Estimated fair value contingent cash consideration | 1,905,000 | ||
Estimated fair value contingent equity consideration | 11,852,400 | ||
Total estimated acquisition consideration | $ 616,000 | 35,090,793 | |
As initially reported | |||
Business Acquisition [Line Items] | |||
Cash | 1,500,000 | ||
Fair value of common shares issued to CMP members | 19,500,000 | ||
Promissory notes | 660,216 | ||
Estimated fair value contingent cash consideration | 1,735,375 | ||
Estimated fair value contingent equity consideration | 10,763,760 | ||
Total estimated acquisition consideration | 34,159,351 | ||
Measurement Period Adjustments | |||
Business Acquisition [Line Items] | |||
Cash | [1] | 0 | |
Fair value of common shares issued to CMP members | [1] | 0 | |
Promissory notes | [1] | 6,572 | |
Estimated fair value contingent cash consideration | [1] | 169,625 | |
Estimated fair value contingent equity consideration | [1] | 1,088,640 | |
Total estimated acquisition consideration | [1] | $ 1,264,837 | |
[1] | As of August 31, 2017, the Company revised its estimate of the contingent cash consideration from $1,735,375 to $1,905,000, and the Company revised its estimate of the contingent equity consideration from $10,763,760 to $11,852,400, to reflect the increased probability of the sellers of CMP reaching the maximum earnouts available. An additional post-closing adjustment of $6,572 was recorded, which resulted in an increase of the promissory notes from $660,216 to $666,788. The balance of the note payable at November 30, 2017 reflects principal payments of $333,395 made to the sellers of CMP. |
ACQUISITION OF CMP WELLNESS, 31
ACQUISITION OF CMP WELLNESS, LLC - Acquisition consideration (Parentheticals) (Details) - USD ($) | 3 Months Ended | 7 Months Ended | ||
Nov. 30, 2017 | Nov. 30, 2016 | Nov. 30, 2017 | ||
Business Acquisition [Line Items] | ||||
Estimated fair value contingent cash consideration | $ 1,905,000 | |||
Estimated fair value contingent equity consideration | 11,852,400 | |||
Promissory notes | 333,393 | |||
Unsecured promissory notes payable increase decrease | $ 666,788 | |||
Repayment of note payable | $ (333,395) | $ (4,967) | ||
As initially reported | ||||
Business Acquisition [Line Items] | ||||
Estimated fair value contingent cash consideration | 1,735,375 | |||
Estimated fair value contingent equity consideration | 10,763,760 | |||
Promissory notes | 660,216 | |||
Measurement Period Adjustments | ||||
Business Acquisition [Line Items] | ||||
Estimated fair value contingent cash consideration | [1] | 169,625 | ||
Estimated fair value contingent equity consideration | [1] | 1,088,640 | ||
Promissory notes | [1] | $ 6,572 | ||
[1] | As of August 31, 2017, the Company revised its estimate of the contingent cash consideration from $1,735,375 to $1,905,000, and the Company revised its estimate of the contingent equity consideration from $10,763,760 to $11,852,400, to reflect the increased probability of the sellers of CMP reaching the maximum earnouts available. An additional post-closing adjustment of $6,572 was recorded, which resulted in an increase of the promissory notes from $660,216 to $666,788. The balance of the note payable at November 30, 2017 reflects principal payments of $333,395 made to the sellers of CMP. |
ACQUISITION OF CMP WELLNESS, 32
ACQUISITION OF CMP WELLNESS, LLC (Detail Textuals) | May 01, 2017USD ($)$ / sharesshares | May 01, 2017USD ($)$ / shares | Nov. 30, 2017USD ($)Sellersshares | Nov. 30, 2017USD ($) |
Business Acquisition [Line Items] | ||||
Cash consideration | $ 150,000 | $ 1,500,000 | ||
Unsecured promissory note principal amount | $ 770,820 | 770,820 | ||
Estimated fair value contingent cash consideration | 1,905,000 | |||
Number of stock issued to investor in exchange for cash | shares | 1,363,674 | |||
Amount of working capital adjustments | $ 104,032 | 104,032 | ||
Unsecured promissory notes payable increase (decrease) | (666,788) | |||
Estimated fair value contingent equity consideration | 11,852,400 | |||
As initially reported | ||||
Business Acquisition [Line Items] | ||||
Cash consideration | 1,500,000 | |||
Estimated fair value contingent cash consideration | 1,735,375 | |||
Estimated fair value contingent equity consideration | $ 10,763,760 | |||
Lancer West Enterprises, Inc And Walnut Ventures | ||||
Business Acquisition [Line Items] | ||||
Limited liability company percentage | 100.00% | |||
CMP Wellness | ||||
Business Acquisition [Line Items] | ||||
Cash consideration | $ 1,500,000 | $ 1,820,000 | ||
Unsecured promissory note principal amount | $ 770,820 | $ 770,820 | ||
Number of aggregate restricted shares | shares | 7,800,000 | |||
Percentage of common stock outstanding | 13.00% | 13.00% | ||
Number of sellers | Sellers | 2 | |||
Estimated fair value contingent cash consideration | $ 1,905,000 | |||
Number of stock issued to investor in exchange for cash | shares | 4,740,960 | |||
Market price on acquisition date | $ / shares | $ 2.50 | $ 2.50 |
CONCENTRATIONS OF RISK (Detail
CONCENTRATIONS OF RISK (Detail Textuals) | 3 Months Ended | |
Nov. 30, 2017CustomerVendor | Nov. 30, 2016Vendor | |
Purchase | Supplier Concentration Risk | ||
Concentration Risk [Line Items] | ||
Number of vendors | Vendor | 2 | 2 |
Concentration risk, percentage | 30.00% | 13.00% |
Revenue | Customer Concentration Risk | ||
Concentration Risk [Line Items] | ||
Concentration risk description | no customers which represented over 10% of the Company's revenues | |
Accounts Receivable | Customer Concentration Risk | ||
Concentration Risk [Line Items] | ||
Concentration risk, percentage | 26.00% | |
Number of customer | 2 | |
Accounts Receivable | Customer Concentration Risk | Customer one | ||
Concentration Risk [Line Items] | ||
Concentration risk description | one customer that accounted for over 10% of accounts receivable | |
Number of customer | 1 |
RELATED-PARTY TRANSACTIONS (Det
RELATED-PARTY TRANSACTIONS (Detail Textuals) - USD ($) | 3 Months Ended | |
Nov. 30, 2017 | Nov. 30, 2016 | |
Related Party Transactions [Abstract] | ||
Rent payment to related parties | $ 53,660 | $ 50,700 |
PROPERTY AND EQUIPMENT - Major
PROPERTY AND EQUIPMENT - Major classes of fixed assets (Details) - USD ($) | Nov. 30, 2017 | Aug. 31, 2017 |
Property, Plant and Equipment [Line Items] | ||
Property, plant and equipment, gross | $ 1,269,965 | $ 1,221,385 |
Accumulated Depreciation | (345,093) | (289,622) |
Property, plant and equipment, net | 924,872 | 931,763 |
Machinery and equipment | ||
Property, Plant and Equipment [Line Items] | ||
Property, plant and equipment, gross | 887,203 | 886,608 |
Vehicles | ||
Property, Plant and Equipment [Line Items] | ||
Property, plant and equipment, gross | 144,845 | 144,845 |
Office Equipment | ||
Property, Plant and Equipment [Line Items] | ||
Property, plant and equipment, gross | 130,085 | 118,387 |
Leasehold improvements | ||
Property, Plant and Equipment [Line Items] | ||
Property, plant and equipment, gross | $ 107,832 | $ 71,545 |
PROPERTY AND EQUIPMENT (Detail
PROPERTY AND EQUIPMENT (Detail Textuals) - USD ($) | 3 Months Ended | |
Nov. 30, 2017 | Nov. 30, 2016 | |
Property, Plant and Equipment [Line Items] | ||
Depreciation | $ 55,472 | $ 29,510 |
Depreciation cost of goods sold | 41,776 | |
Depreciation and Amortization | ||
Property, Plant and Equipment [Line Items] | ||
Depreciation | $ 13,696 |
INTANGIBLE ASSETS (Details)
INTANGIBLE ASSETS (Details) - USD ($) | May 01, 2017 | Nov. 30, 2017 |
Asset Acquisition Consideration: | ||
Cash | $ 150,000 | $ 1,500,000 |
Fair value of common shares issued to seller | 466,000 | |
Total estimated acquisition consideration | $ 616,000 | $ 35,090,793 |
INTANGIBLE ASSETS (Details 1)
INTANGIBLE ASSETS (Details 1) - USD ($) | May 01, 2017 | Nov. 30, 2017 | May 03, 2017 |
Acquired Finite-Lived Intangible Assets [Line Items] | |||
Inventory | $ 655,970 | $ 26,716 | |
Net assets acquired | 616,000 | ||
Total fair value of consideration | $ 616,000 | $ 35,090,793 | |
Domain name | |||
Acquired Finite-Lived Intangible Assets [Line Items] | |||
Finite-lived intangible assets: | $ 589,284 |
INTANGIBLE ASSETS (Details 2)
INTANGIBLE ASSETS (Details 2) - USD ($) | 3 Months Ended | |
Nov. 30, 2017 | Nov. 30, 2016 | |
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Value | $ 3,989,284 | |
Accumulated Amortization | $ (446,794) | |
Roll-Uh-Bowl | Domain name | ||
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Weighted Average Estimated Useful Life | 5 years | |
Gross Carrying Value | $ 589,284 | $ 0 |
Accumulated Amortization | $ (77,350) | 0 |
CMP Wellness | Trade name | ||
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Weighted Average Estimated Useful Life | 6 years | |
Gross Carrying Value | $ 2,600,000 | 0 |
Accumulated Amortization | $ (252,777) | 0 |
CMP Wellness | Non-compete agreement | ||
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Weighted Average Estimated Useful Life | 4 years | |
Gross Carrying Value | $ 800,000 | 0 |
Accumulated Amortization | $ (116,667) | $ 0 |
INTANGIBLE ASSETS (Detail Textu
INTANGIBLE ASSETS (Detail Textuals) | May 03, 2017USD ($)$ / sharesshares | May 01, 2017USD ($)$ / shares | May 01, 2017USD ($)$ / shares | Nov. 30, 2017USD ($)Segmentshares | Nov. 30, 2017USD ($) | Nov. 30, 2016USD ($) |
Acquired Finite-Lived Intangible Assets [Line Items] | ||||||
Cash consideration | $ 150,000 | $ 1,500,000 | ||||
Estimated fair value contingent cash consideration | 1,905,000 | |||||
Estimated fair value contingent equity consideration | (11,852,400) | |||||
Number of reportable segments | Segment | 1 | |||||
Finite lived intangible assets, Gross carrying value | $ 3,989,284 | 3,989,284 | ||||
Amortization expense | $ 188,118 | |||||
Roll-Uh-Bowl | Asset Purchase Agreement | ||||||
Acquired Finite-Lived Intangible Assets [Line Items] | ||||||
Cash consideration | $ 150,000 | |||||
Stock issued for acquisitions (in shares) | shares | 200,000 | |||||
Value of stock issued for acquisitions | $ 466,000 | |||||
Additional cash consideration | $ 100,000 | |||||
Additional stock issued for acquisitions (in shares) | shares | 400,000 | |||||
Estimated fair value contingent cash consideration | $ 50,000 | |||||
Estimated fair value contingent equity consideration | 466,000 | |||||
Reduced the basis of the intangible asset | $ 516,000 | |||||
Market price | $ / shares | $ 2.33 | |||||
Roll-Uh-Bowl | Domain name | ||||||
Acquired Finite-Lived Intangible Assets [Line Items] | ||||||
Weighted average estimated useful life | 5 years | |||||
Finite lived intangible assets, Gross carrying value | $ 589,284 | 589,284 | $ 0 | |||
CMP Wellness | ||||||
Acquired Finite-Lived Intangible Assets [Line Items] | ||||||
Cash consideration | $ 1,500,000 | $ 1,820,000 | ||||
Stock issued for acquisitions (in shares) | shares | 4,740,960 | |||||
Estimated fair value contingent cash consideration | $ 1,905,000 | |||||
Market price | $ / shares | $ 2.50 | $ 2.50 | ||||
CMP Wellness | Trade name | ||||||
Acquired Finite-Lived Intangible Assets [Line Items] | ||||||
Weighted average estimated useful life | 6 years | |||||
Finite lived intangible assets, Gross carrying value | $ 2,600,000 | 2,600,000 | 0 | |||
CMP Wellness | Non-compete agreement | ||||||
Acquired Finite-Lived Intangible Assets [Line Items] | ||||||
Weighted average estimated useful life | 4 years | |||||
Finite lived intangible assets, Gross carrying value | $ 800,000 | $ 800,000 | $ 0 |
ACCRUED EXPENSES AND OTHER CU41
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) - USD ($) | Nov. 30, 2017 | Aug. 31, 2017 |
Accrued Liabilities And Other Liabilities Current [Abstract] | ||
Customer deposits | $ 710,063 | $ 342,909 |
Accrued compensation | 189,748 | 245,975 |
Income tax payable | 273,497 | 219,082 |
Credit card liabilities | 51,854 | 142,157 |
Deferred rent | 25,301 | 25,881 |
Sales tax payable | 13,591 | 17,182 |
Accrued expenses and other current liabilities | $ 1,264,054 | $ 993,186 |
NOTES PAYABLE - Automobile Cont
NOTES PAYABLE - Automobile Contracts Payable (Details) | Aug. 31, 2017USD ($) |
Debt Disclosure [Abstract] | |
2,018 | $ 20,483 |
2,019 | 17,453 |
2,020 | 10,679 |
2,021 | 3,063 |
Total | $ 51,678 |
NOTES PAYABLE (Detail Textuals)
NOTES PAYABLE (Detail Textuals) - USD ($) | 3 Months Ended | |
Nov. 30, 2017 | Aug. 31, 2017 | |
Debt Disclosure [Abstract] | ||
Unsecured promissory note | $ 770,820 | |
Amount of working capital adjustments | 104,032 | |
Unsecured promissory notes payable increase (decrease) | $ (666,788) | |
Interest rate | 1.15% | |
Accrued interest on the promissory notes | $ 1,438 | |
Notes payable, current | 358,253 | $ 689,450 |
Payments made during quarter end | $ 333,394 | |
Percentage of average interest rate | 6.00% |
LOAN AGREEMENT (Detail Textuals
LOAN AGREEMENT (Detail Textuals) - Loan And Security Agreement - Kim International Corporation - Gerber Finance Inc. - Revolving Credit Facility - USD ($) | Nov. 06, 2017 | Nov. 30, 2017 |
Line of Credit Facility [Line Items] | ||
Maximum borrowing capacity | $ 2,000,000 | |
Fair value of amount outstanding | $ 1,502,418 | |
Percentage of threshold maximum borrowing capacity | 85.00% | |
Maturity date | Nov. 6, 2019 | |
Margin added in interest rate | 3.00% |
STOCKHOLDERS' EQUITY - Schedule
STOCKHOLDERS' EQUITY - Schedule of assumptions used (Details) | 3 Months Ended | |
Nov. 30, 2017 | Nov. 30, 2016 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Expected volatility | 60.00% | 60.00% |
Weighted-average volatility | 60.00% | 60.00% |
Dividend yield | 0.00% | 0.00% |
Expected forfeiture rate | 33.00% | 33.00% |
Minimum | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Expected term (years) | 1 year | 1 year |
Risk-free interest rate | 1.14% | 0.85% |
Maximum | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Expected term (years) | 4 years | 4 years |
Risk-free interest rate | 1.97% | 1.57% |
STOCKHOLDERS' EQUITY - Stock op
STOCKHOLDERS' EQUITY - Stock option activity (Detail 1) - USD ($) | 3 Months Ended | ||
Nov. 30, 2017 | Nov. 30, 2016 | Aug. 31, 2017 | |
No. of Options | |||
Balance Outstanding | 5,275,500 | ||
Granted | 960,500 | ||
Exercised | 10,000 | ||
Forfeited | 37,500 | ||
Balance Outstanding | 6,188,500 | ||
Exercisable | 1,999,000 | ||
Weighted Average Exercise Price | |||
Balance Outstanding | $ 1.73 | ||
Granted | 2.25 | $ 1.83 | |
Exercised | 1 | ||
Forfeited | 1.83 | ||
Balance Outstanding | 1.81 | ||
Exercisable | $ 0.94 | ||
Balance Outstanding, Weighted Average Remaining Contractual Term | 8 years 9 months 18 days | 8 years | |
Granted, Weighted Average Remaining Contractual Term | 9 years 10 months 24 days | ||
Exercisable, Weighted Average Remaining Contractual Term | 8 years 2 months 12 days | ||
Aggregate Intrinsic Value, Balance Outstanding | $ 6,389,845 | $ 917,610 | |
Exercisable, Aggregate Intrinsic Value | $ 4,242,215 |
STOCKHOLDERS' EQUITY - Non-vest
STOCKHOLDERS' EQUITY - Non-vested options (Detail 2) | 3 Months Ended |
Nov. 30, 2017$ / sharesshares | |
No. of Options | |
Nonvested | shares | 3,679,972 |
Granted | shares | 960,500 |
Exercised | shares | (10,000) |
Vested | shares | (403,472) |
Forfeited | shares | (37,500) |
Nonvested | shares | 4,189,500 |
Weighted Average Grant-Date Fair Value | |
Nonvested | $ / shares | $ 1,878,144 |
Granted | $ / shares | 2,158,955 |
Exercised | $ / shares | 8,003 |
Vested | $ / shares | (92,902) |
Forfeited | $ / shares | (69,300) |
Nonvested | $ / shares | $ 4,260,701 |
STOCKHOLDERS' EQUITY (Detail Te
STOCKHOLDERS' EQUITY (Detail Textuals) - USD ($) | 3 Months Ended | |
Nov. 30, 2017 | Aug. 31, 2017 | |
Stockholders' Equity Note [Abstract] | ||
Preferred stock, shares authorized | 10,000,000 | 10,000,000 |
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Common stock, shares authorized | 265,000,000 | 265,000,000 |
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common stock, shares issued | 60,006,178 | 58,607,066 |
Common stock, shares outstanding | 60,006,178 | 58,607,066 |
Number of stock issued to investor in exchange for cash | 1,363,674 | |
Value of stock issued to investor in exchange for cash | $ 2,045,505 | |
Value of shares under stock payables | $ 2,564,050 | |
Number of shares under stock payables | 1,709,366 |
STOCKHOLDERS' EQUITY (Detail 49
STOCKHOLDERS' EQUITY (Detail Textuals 1) - USD ($) | 3 Months Ended | |
Nov. 30, 2017 | Nov. 30, 2016 | |
Stockholders' Equity Note [Abstract] | ||
Stock compensation expense | $ 381,743 | $ 115,244 |
Number of shares issued to consultants for services rendered | 27,231 | |
Value of stock issued to consultants for services rendered | $ 20,000 | |
Value of stock issued to consultants for prepaid services | 34,077 | |
Total value of stock issued to consultants for services rendered and prepaid services | 54,077 | |
Prepaid service expenses amortized | $ 14,602 |
STOCKHOLDERS' EQUITY (Detail 50
STOCKHOLDERS' EQUITY (Detail Textuals 2) - USD ($) | 3 Months Ended | |
Nov. 30, 2017 | Nov. 30, 2016 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Weighted average remaining contractual term | 8 years 9 months 18 days | 8 years |
Number of shares issued | 960,500 | |
Weighted-average grant-date fair value of options granted | $ 2.25 | $ 1.83 |
Weighted-average grant-date fair value of options forfeited | $ 1.83 | |
2016 Stock Incentive Plan | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Number of shares issued | 5,000,000 | |
Share-based payment award vesting period | 3 years | |
Weighted average remaining contractual term | 10 years | |
Number of shares issued | 960,500 | 431,500 |
Number of shares issued | 4,709 | |
Unrecognized compensation cost related to non-vested share | $ 370,325 | |
Weighted-average period, cost expected to be recognized | 1 year 10 months 24 days | |
Fair value of shares vested | $ 214,031 | |
Number of shares issued for stock option cashless exercised | 10,000 |
COMMITMENTS AND CONTINGENCIES -
COMMITMENTS AND CONTINGENCIES - Minimum future commitments (Details) | Aug. 31, 2017USD ($) |
Commitments and Contingencies Disclosure [Abstract] | |
2,018 | $ 453,619 |
2,019 | 601,102 |
2,020 | 444,420 |
2,021 | 322,604 |
2,022 | 332,278 |
Total | $ 2,154,023 |
COMMITMENTS AND CONTINGENCIES52
COMMITMENTS AND CONTINGENCIES (Detail Textuals) | May 01, 2017USD ($) | May 01, 2017USD ($) | Jul. 31, 2017USD ($) | Nov. 30, 2017USD ($)Sellersshares | Nov. 30, 2016USD ($) | Nov. 30, 2017USD ($) |
Operating Leased Assets [Line Items] | ||||||
Monthly payments | $ 53,660 | $ 50,700 | ||||
Operating leases, rental expense, related to office, retail and warehouse space | $ 160,093 | $ 94,418 | ||||
Cash consideration | $ 150,000 | $ 1,500,000 | ||||
CMP Wellness | ||||||
Operating Leased Assets [Line Items] | ||||||
Number of sellers | Sellers | 2 | |||||
Cash consideration | $ 1,500,000 | $ 1,820,000 | ||||
Stock issued for acquisitions (in shares) | shares | 4,740,960 | |||||
Lease expires on August 1, 2022 | Minimum | ||||||
Operating Leased Assets [Line Items] | ||||||
Monthly payments | $ 24,480 | |||||
Lease expires on August 1, 2022 | Maximum | ||||||
Operating Leased Assets [Line Items] | ||||||
Monthly payments | 28,379 | |||||
Lease expires in January 2019 | Minimum | ||||||
Operating Leased Assets [Line Items] | ||||||
Monthly payments | 4,031 | |||||
Lease expires in January 2019 | Maximum | ||||||
Operating Leased Assets [Line Items] | ||||||
Monthly payments | 4,143 | |||||
Lease commenced on July 15, 2016 and expires on January 31, 2020 | Minimum | ||||||
Operating Leased Assets [Line Items] | ||||||
Monthly payments | 14,985 | |||||
Lease commenced on July 15, 2016 and expires on January 31, 2020 | Maximum | ||||||
Operating Leased Assets [Line Items] | ||||||
Monthly payments | 16,022 | |||||
Lease runs through March 31, 2020 | Minimum | ||||||
Operating Leased Assets [Line Items] | ||||||
Monthly payments | 4,800 | |||||
Lease runs through March 31, 2020 | Maximum | ||||||
Operating Leased Assets [Line Items] | ||||||
Monthly payments | $ 7,300 |
SUBSEQUENT EVENTS (Detail Textu
SUBSEQUENT EVENTS (Detail Textuals) - USD ($) | 1 Months Ended | 3 Months Ended |
Jan. 12, 2018 | Nov. 30, 2017 | |
Subsequent Event [Line Items] | ||
Number of shares issued for stock option exercised | 10,000 | |
Subsequent event | ||
Subsequent Event [Line Items] | ||
Number of shares issued for stock option exercised | 67,500 | |
Value of stock issued as exercise of stock options | $ 78,300 |